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Abstract 
 
 
 
Biomedical Optics as an interdisciplinary field of science has been developed during many 
years and is experiencing tremendous growth, to cover a wide range of optical techniques 
and methods, utilized for medical therapeutic and diagnostic purposes. Biomedical optics 
contributes by introducing methods and creation of devices used in healthcare of various 
specialties, such as ophthalmology, cardiology, surgery, dermatology, oncology, 
radiology, etc. Each of these specialities might take advantages of different optical 
techniques and methods such as: laser surgery, optical thermotherapy, optical tomography 
and imaging, optical biopsies, photodynamic therapy, in vitro diffuse spectroscopy, etc1.  
 
Among all of the mentioned methods and techniques; photodynamic therapy, medical 
applications of in vitro diffuse spectroscopy, and optical biopsies, are the main topics 
covered by the projects presented in this book. 
 
This thesis is presented in two parts. Part one, consists of seven chapters as an introduction 
to the scientific works that are presented in five original papers in part two. Part one, 
covers areas that might not have been explicitly apparent in the papers, but have formed a 
basis needed to interpret data, and to understand the background for the various studied 
phenomena. 
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Chapter 1 
 
 
 
 
 
Introduction  
 
 
 
                                                                 And God said, "Let there be light,"  
                                                                                          and there was light. 
 
                                                                                                                   The Holy Bible 
 
 
 
 
 
Let There Be Light! In the beginning, it was dark and cold. There was no sun, no light, 
no earth, and no solar system. There was nothing, just the empty void of space. Then 
slowly, about 4.5 billion years ago, a huge cloud of gas and dust was formed. Eventually 
this cloud contracted and grew into a central molten mass that became our Sun. At first the 
sun was a molten glow. As the core pressure increased, and the temperature rose to 
millions of degrees - a star was born. Through the process of thermonuclear hydrogen 
fusion, the sun began to shine. This is the nebular hypothesis, first proposed in 1755 by the 
great German philosopher, Immanuel Kant2. It is said that, about 4 billion years ago, soon 
after the Sun was formed, the Earth and the other planets in our solar system were formed 
from violent explosions and spin offs from the process that created the Sun2. Gradually 
oceans appeared and sunlight and water gave birth to life. Without light, there would be no 
life. Life was dependent on three things being present: a) the basic long molecule building 
block, carbon, b) water, and c) light. Eventually the oceans formed a rich organic soup that 
ultimately bore life. Somehow, as the primitive ocean organisms developed, one managed 
to develop a molecule that could use the energy of sunlight to produce food for itself. 
Sunlight, water, carbon dioxide, and simple inorganic elements were necessary and 
sufficient to develop and sustain an ecological system. The plant was born and the process 
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of photosynthesis had begun2. In this process, chlorophyll of the green plants absorbs the 
solar radiation, and by means of water and carbon dioxide, forms carbohydrates and 
oxygen, which both of them are basic requirements for animal life.  
 
The effects of sun light on human body are also very interesting. In human body many 
photochemical and photobiological processes take place. The production of vitamin D, 
after absorption of ultraviolet (UV) radiation in the skin, is one of the important 
photochemical reactions3. A wide variety of physiological and metabolic processes in the 
body depend on the presence of vitamin D. Another effect of UV radiation on the skin, is 
simulating the production of the dark pigment in the skin, called melanin, which prevents 
the penetration of UV radiation into the deeper layers of the skin4,5. On the other hand, the 
harmful effects of UV radiation on biological systems should not be forgotten as well. 
When UV radiation is absorbed by DNA, some irreversible changes are introduced by 
photochemical reactions, causing mutations in the genetic code. Most often, the back-up 
systems developed through evolution manage to repair these changes; however, sometimes 
when the protective systems fail, the mutations lead to cancer6. There are processes that 
reduce and control the atmospheric transmission of UV radiation. These processes are 
based on Rayleigh scattering by air molecules, Mie scattering by clouds, and absorption by 
ozone; though, still significant amounts of UV radiation reach the Earth and influence life 
on it7-9. One of the most fascinating human reaction to light is the response of the 
photoreceptors in the eyes to the light, which enables visual perception10. 
 
The beneficial properties of light employed for medicinal purposes have a long tradition. 
"Light therapy", also called, Phototherapy, was known by the Egyptians, the Indians and 
the Chinese, and has been applied since 3000 years ago. During many years, many optical 
methods and devices have been introduced and developed to take best advantage of light 
properties employed in science and technology in general, and in medicine, in particular, 
for diagnostic and therapeutic purposes. The invention of the Laser was the turning point 
in this direction. The principle of the laser was first known in 1917, when Albert Einstein 
described the theory of stimulated emission. However, it was not until the late 1940s that 
utilizing this principle for practical purposes was begun. Laser was a remarkable technical 
breakthrough, but in its early years it was something of a technology without a purpose. 
Later on, powerful lasers were developed for use in surgery and other areas of science and 
technology, where a moderately powerful, pinpoint source of heat was needed11.  
 
Biomedical Optics as an interdisciplinary field of science has been developed during many 
years and is experiencing tremendous growth, to cover a wide range of optical techniques 
and methods, utilized for medical therapeutic and diagnostic purposes. Biomedical optics 
contributes in the introducing methods and creation of devices used in healthcare of 
various specialties, such as ophthalmology, cardiology, surgery, dermatology, oncology, 
radiology, etc. Each of these specialities might take advantages of different optical 
techniques and methods such as: laser surgery, optical thermotherapy, optical tomography 
and imaging, optical biopsies, photodynamic therapy (PDT), in vitro diffuse spectroscopy, 
etc1.  
 
Among all of the mentioned methods and techniques; PDT, medical applications of in 
vitro diffuse spectroscopy, and optical biopsies, are the main categories covering the 
projects and researches presented in this book.  
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PDT is a treatment modality based on photochemical reaction involving oxygen. It is a 
relatively new technique for local treatment, which is mostly applied to malignant tumors. 
PDT requires three simultaneously present components for cytotoxicity: a photosensitizer, 
light, and oxygen12. A photosensitive compound or pro-drug is administrated systemically 
or topically to the patient, and the photoactive agent utilized is most often selectively 
accumulated into the malignant tissue. The chemical reaction occurs just when the 
irradiation starts. The photosensitizer molecule is excited to its higher energy level by 
absorbing the energy of the illuminating light. The photosensitizer molecule releases then 
the excess energy once they are returning to the ground state. This excess energy is 
transferred to the oxygen molecules present, and produces singlet oxygen. Finally, the 
cytotoxicity of the produced singlet oxygen leads to the cell death.  Many factors effect 
and control the optimization of the treatment and the efficacy of PDT. The diffusion 
coefficient or diffusivity of a pro-drug sensitizer (methyl-aminolevulenic acid), has been 
studied during topical application of the drug. This investigation is presented in Paper IV.  
 
Besides being a non-invasive modality, the main advantages of PDT are the selectivity, the 
smooth and rapid healing and the ability of repeating the treatment on the same area, if 
necessary13,14. On the other hand, one of the main disadvantages of this technique is the 
limited light penetration. To overcome this limitation interstitial photodynamic therapy 
(IPDT) has been introduced and developed, which by use of optical fibers inserted in the 
tumor mass facilitates light transportation to any deep laying target tissue.  
 
Another concept investigated in the work presented in this thesis, is the in vitro diffuse 
spectroscopy for biomedical applications. The investigated physical disorders are 
associated with physiological, biochemical and morphological changes of the tissue. All 
these alternations will affect the interaction processes between light and tissue from 
molecular to cell layer level15. Light interaction with and propagation through biological 
tissue are thus investigated. The light propagation in turbid biological media is governed 
by both its absorption and scattering properties. This type of spectroscopic measurements 
can provide information in many different scientific fields including for medicine. In 
medicine, the knowledge of tissue optical properties has found its application in cancer 
diagnostics and therapy. Tissue optical properties are mainly known as absorption 
coefficient (µa), scattering and reduced scattering coefficient (µs, µs'), and anisotropy 
factor (g). While absorption coefficient provides information on the concentration of 
various chromospheres, the scattering properties and anisotropy factor, provide important 
information about the form, size, and the concentration of different scattering components 
in tissue. Measurements of the optical properties of tissue can be performed in vivo or in 
vitro. Most in vivo measurements are based on frequency domain, time-resolved, or 
spatially resolved measurements. To extract the optical properties, an inverse algorithm 
usually based on the diffusion approximation and the fact that the tissue is relatively 
homogeneous within a relatively large probe volume, is utilized.  
 
The most common technique for extracting the optical properties of tissue in vitro is the 
Integrating Sphere (IS) method. This technique requires, however, bulky instrumentation, 
inconvenient sample handling and complicated measurements techniques. In Paper I, the 
principles of a fast and accurate algorithm, in combination with a new compact device 
developed for determining tissue optical properties, in vitro, are described. In Paper II, the 
optical properties of porcine brain tissue has been measured using this new 
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instrumentation and the results are compared with the measured results obtained from an 
integrating sphere system. Both systems were calibrated with a set of tissue phantoms with 
known optical properties. Paper V, is generally introducing the same work presented in 
Paper II, while a different calibration method is employed.  
 
The other concept to discuss is "Optical biopsy", which by using the corresponding 
modification of the optical signals from light-tissue interaction, forms spectra fingerprints 
for tissue characterization. The spectral distribution in all optical diagnostic techniques, 
depend on the illumination and collection light geometry. Depending on the type of light 
interaction/emission with/from tissue and the absorbing molecules, four main categories of 
diagnostic techniques are identified: 1- Laser-induced fluorescence (LIF), 2- Raman 
spectroscopy, 3- Laser-Doppler flowmetry, and 4- Elastic scattering spectroscopy. In all of 
these techniques, the outcome results are based on the optical properties of the tissue and 
the induced wavelength of the applied light. In ideal situation for detecting geometry the 
total distribution of the scattered light is collected, which can be done by utilizing 
integrating sphere method. The problem is that this technique is not clinically practical. 
Instead, a geometry based on optical fibers is suggested.  
 
Combining LIF and PDT, provide an important tool for diagnostic and therapeutic 
purposes. In Paper III, LIF is used in connection with IPDT to investigate any temperature 
changes during (maybe caused by) the treatment. Temperature is an important factor that 
can affect the result in PDT and IPDT. Due to the fact that the fluence rate is very high at 
the fiber tip for IPDT with bare end fibers, it would be interesting to investigate the local 
temperature change during such treatment. In this study, the temperature was measured 
during PDT/IPDT using fibers having a small crystal with temperature dependent 
fluorescence. The influence of the fiber geometry and different scattering properties of the 
tissue were investigated.  
 
In a study not presented in this thesis, the optical properties of human brain tissue (normal 
and lesion tissue) have been measured using an integrating sphere system. These 
measurements were performed in order to compare the results obtained using IS and 
Optical Coherence Tomography (OCT) techniques. OCT is a very important optical 
technique in superficial tissue tomography16. Specific advantages of OCT compared to 
other tomography techniques are its high depth resolution, relatively high probing depth in 
scattering media, contact-free and non-invasive operation, and the possibility to create 
various function dependent image contrast methods17.  
 
 
 
 
 
 
  
 
 
 
Chapter 2 
 
 
 
 
 
Interaction of light with tissue 
 
 
  
   Light is Love revealed. 
  Light is Life manifested. 
     Light is God fulfilled. 
 
                                                                                                                         Sri Chinmoy 
 
 
 
 
 
2.1 Introduction 
 
Life in any form is surrounded by light. Interacting with matter, light participates in so 
many different processes. Interaction of light with matter can reveal important information 
about the nature of the matter. The electromagnetic spectrum, shown in Figure 2.1, ranges 
from radio wave to gamma radiation; while the term "light" generally refers to that portion 
of the spectrum with wavelength between 400 nm and 700 nm, which can be seen by 
naked eye. Electromagnetic radiation in general and light in particular, has a dual nature as 
both particles and waves.  
 
Considering the duality nature of light, the concept of light-tissue interaction is to be 
discussed. Because of its dualistic nature and also depending on the type of the 
experiment, we can look at it in two ways. One is as changing electric and magnetic fields, 
which propagate through space, forming an electromagnetic wave. This wave has 
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amplitude, which is the brightness of the light, wavelength, which is the color of the light, 
and an angle at which it is vibrating, called polarization. This was the classical 
interpretation, crystallized in Maxwell Equations, which held sway until Planck, Einstein 
and others came along with quantum theory. In terms of the modern quantum theory, 
electromagnetic radiation consists of particles called photons, which are packets-quanta, of 
energy, which move at the speed of light. In this particle view of light, the brightness of 
the light is the number of photons, and the color of the light is the energy contained in 
each photon. 
 
 
 
 
Figure 2.1 Electromagnetic radiation spectrum. 
 
To describe the wave nature of the electromagnetic radiation, the terms wavelength λ, or 
frequency ν are used; while in the particle description of the electromagnetic radiation, the 
energy Е, is used. These quantities are connected as 
 
eq).eV(E
c.h.h)J(E =
λ
=ν=                                           (2.1) 
 
where h denotes Planck's constant, c the speed of light, and qe the electron unit charge. 
E(J) and E(eV) are energy in joules and energy in electron-volts; respectively. 
 
Interacting different parts of the electromagnetic spectrum with matter have different 
effects on it.  For example, the human body is quite transparent to the low frequency radio 
waves, while moving to microwaves and infrared to visible light, the body absorbs more 
and more. In the lower ultraviolet range, all the UV radiation from the sun is absorbed in 
the thin outer layer of skin, while moving towards the X-ray region of the electromagnetic 
spectrum, the body becomes transparent again. 
 
 
2.2 Properties of light 
 
Both the wave and particle descriptions of light appear in tissue optics. When light is 
passing through a tissue with regular structure such as flowing blood, as disc-shaped cells, 
a characteristic asymmetry can be found in the angular distribution of the scattered light, a 
phenomenon can be taken into account using the wave propagation properties of light. 
While in the studies of thick and dense tissues, such as breast tissue, the wave 
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characteristics of light are ignored as the properties associated with the wave nature of 
light are lost. Instead, considering the particle nature of light, a model based on the light 
propagation as a stream of energy quanta, takes place15.  
 
 
2.2.1 Electromagnetic wave theory 
 
Electromagnetic waves are waves of electric and magnetic forces, where a wave motion is 
defined as propagation of disturbances in a physical system. A change in the electric field 
is accompanied by a change in the magnetic field, and vice versa. These phenomena were 
described in 1865 by James Clerk Maxwell in four equations, which have come to be 
known as the Maxwell Equations. From the classical point of view, light as any 
electromagnetic waves, satisfies the Maxwell equations. These equations for macroscopic 
electromagnetic case at interior points in matter, may in SI units be written as18,18,19 
 
                                                       F. ρ=∇ D                                                                    (2.2) 
                                                       0
t
=
∂
∂
+×∇ BE                                                          (2.3) 
 
                                                       0. =∇ B                                                                      (2.4) 
 
                                                       
tf ∂
∂
+=×∇ DJH                                                       (2.5) 
 
where E is the electric field, B the magnetic induction, J the current density, and ρ the 
volume charge density. D and H are defined by 
 
                                                       PED +ε= 0                                                               (2.6) 
 
                                                       M
0
−
μ
=
BH                                                               (2.7) 
 
where D is the displacement, H the magnetic field, P the electric polarization, and M the 
magnetization. The permittivity and the permeability of the free space are represented by 
ε0 and µ0, respectively. All the Eqs. (2.2) to (2.7) must be supplemented with the 
following constitutive relations 
 
                                                       EJ σ=                                                                       (2.8) 
 
                                                       HB μ=                                                                      (2.9) 
 
                                                       EP χε= 0                                                                 (2.10) 
 
where σ is the conductivity, µ the permeability, and χ the electric susceptibility. These 
coefficients depend on the characteristics of the medium under consideration. Regard to 
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the electromagnetic terms which a bulk non-scattering medium may be approximated by a 
homogeneous and isotropic continuum of free charges and small dipoles20; these 
coefficients will be assumed to be independent of position (the medium is homogeneous), 
and independent of directions (the medium is isotropic).  
 
In the time harmonic case, the Maxwell equations may be written in complex form as18 
 
0)),r(.( 0r =ωεε∇ E                                                         (2.11) 
 
),r(i),r( 0 ωωμ=ω×∇ HE                                              (2.12) 
 
0),r(. =ω∇ H                                                                  (2.13) 
 
),r(i),r( 0r ωεωε−=ω×∇ EH                                         (2.14) 
 
where r is the position vector, εr the complex permittivity, and ω the angular frequency of 
the harmonic fields. Considering the constitutive relations in Eq. (2.8) to (2.10), the 
complex permittivity is given by 
 
ω
σ
+ωχ+ε=ε i))(1(0r                                               (2.15) 
 
2.2.2 Plane wave propagation 
 
Maxwell equations show that propagation of electromagnetic waves must satisfy the 
following wave equations 
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where c0 is the speed of light in vacuo, and nc the complex refractive index that is defined 
by 
 
nc = n + iκ = rε                                                      (2.18) 
 
The solutions to the Eq. (2.16) and (2.17) yield the plane-wave equations as 
 
)tixiexp( ω−⋅= kEE 0                                                 (2.19) 
 
)tixiexp( ω−⋅= kHH 0                                               (2.20) 
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where E0 and H0 are constant vectors, and k is the wave vector indicating the direction of 
propagation. The wave vector may be complex20 
 
k = k' + ik"                                                     (2.21) 
 
where k' and k" are real vectors. If Eq. (2.21) is substituted in Eqs. (2.19) and (2.20), we 
obtain 
 
)tix'iexp()x"exp( ω−⋅⋅−= kkEE 0                                   (2.22) 
 
)tix'iexp()x"exp( ω−⋅⋅−= kkHH 0                                  (2.23) 
 
)x"exp( ⋅−kE0  and )x"exp( ⋅−kH0  are the amplitudes of the electric and magnetic waves, 
and )tix'i( ω−⋅k is the phase of the waves. If k' and k" are parallel, the waves are said to 
be homogeneous; if k' and k" are not parallel, the waves are said to be inhomogeneous 
(such as waves propagating in vacuum). It should be mentioned that plane waves are 
physically unrealizable because they are infinite in time and space; and only certain 
electromagnetic waves that satisfy the Maxwell equations are physically 
realizable.  
 
 
2.2.3 The Poynting vector 
 
Considering an electromagnetic field (E, H); the magnitude and direction of the rate of 
transfer of electromagnetic energy at all points of space, is quantified by the Poynting 
vector as the following,  
 
HES ×=                                                      (2.24) 
 
The Poynting vector is very important in propagation, absorption and scattering problems 
of electromagnetic waves. For time-harmonic fields, S is a rapidly varying function of 
frequency. Regard to the rapid oscillations of the Poynting vector, it is more convenient to 
apply the time-averaged Poynting vector for time-harmonic fields, 
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The time-averaged Poynting vector for a plane harmonic wave is given by 
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The magnitude of the time-averaged Poynting vector, which is denoted by the symbol I or 
E, is called irradiance,  
 
S=I                                                         (2.27)  
 
The dimension of irradiance is energy per unit area and time; and so often, the term 
intensity is used to denote irradiance.  
 
From Eq. (2.26) it is not only seen that irradiance is in the direction of propagation, i.e. ez; 
and therefore parallel to k; but also it appears that as the wave transverses the medium, the 
irradiance is also exponentially attenuated as a function of distance in the propagation 
direction. 
 
 
2.3 Absorption 
 
By considering the definition of irradiance and Eq. (2.26), the following equation, known 
as Beer's law, is obtained. 
 
zaeII 0
μ−
=                                                    (2.28) 
 
where I0 is the irradiance at z = 0, and µa (m
-1) is the absorption coefficient. 
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Therefore, the rate at which electromagnetic energy is removed from the wave as it 
propagates through the medium, and/or in other word, the absorption coefficient µa at a 
given wavelength λ; is determined by the imaginary part κ of the complex refractive index 
nc. This definition is based on the macroscopic electromagnetic term with a continuum 
medium assumption.  
 
The absorption coefficient (µa) is the probability per unit distance for an absorption event 
to occur. In many chemical applications with homogeneous and non-scattering samples, 
the Beer-Lamberts law, Eq. (2.28), can be used for measuring the absorption coefficient. 
In turbid media, such as biological tissues, the Beer-Lambert law cannot, however, be 
utilized directly, as the path length of the light is not known. Figure 2.2 shows how the 
intensity of light directed onto a cuvette decreases exponentially through an absorbing 
medium according to the Beer-Lambert law. 
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Figure 2.2 Light absorption in a cuvette with a homogeneous absorbing medium 
according to the Beer-Lambert law, modified from Ref21. 
 
 
2.3.1 Quantum theory 
 
From the microscopic point of view and according to the quantum theory, the energy 
levels in atoms and molecules are quantized. If the energy of the incident photon (һν) 
matches the gap between to energy levels in the molecule, it can be absorbed by the 
molecule, otherwise the molecule will be transparent to that radiation, and it will pass 
through. When photon is absorbed by the molecule, the transitions between the specific 
energy levels can be divided into high energy electronic transitions (UV and VIS regions) 
and low energy vibrational or rotational transitions (NIR and IR regions)22,23. As it is 
shown in Jablonski diagram, Figure 2.3, after the absorption of a photon and the 
subsequent excitation to the higher energy level (S0 --> Sn), the molecule relaxes down to 
the lowest excited energy level; then relaxation from the lowest excited state to the ground 
state may happen through different processes. If the spin state of the initial and the final 
energy levels be the same (S1 --> S0), the relaxation is called fluorescence.  
 
If the spin state of the initial and the final energy levels are different (T1 --> S0), the 
relaxation is called phosphorescence. Fluorescence and phosphorescence are radiative 
processes. Transitions between the same spin states are called internal conversion (IC), 
while such transitions between different spin states are called intersystem crossing (ISC). 
 
Usually the stable ground state in most molecules is the singlet state (S0 in Figure 2.3), 
while the triplet states (T1, 2 in Figure 2.3) are unstable excited states with an increased 
internal energy. Oxygen is one of the rare molecules for which the lowest triplet state is 
the ground state. Excited molecular oxygen is in the singlet state. This is important in the 
photodynamical reaction occurring during photodynamic therapy (PDT)24, (see Chapter 7). 
There is another type of photon-electron transition called stimulated emission, which 
happens in atoms. 
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Figure 2.3 Jablonski diagram. Energy levels and the possible pathways following light 
absorption by an absorbing molecule (chromophore). Modified from Ref.22,25. 
 
 
When an atom or molecule already is in an excited state, then an incoming photon with 
quantum energy equal to the excess internal energy of that atom or molecule, can produce 
a second photon of the same energy by stimulating the atom or molecule to fall down to its 
lower energy state, shown in Figure 2.4. This is the principle of the light amplification 
happens in lasers (Light Amplification by Stimulated Emission of Radiation). Photons 
produced by stimulated emission have the same phase and frequency, resulting in very 
intense and coherent light (laser).  
 
 
 
 
Figure 2.4 Stimulated emission. The electron in the excited state falls into the lower state 
emitting a photon. 
  
 
2.3.2 Tissue absorption 
 
Inside tissue, light can be absorbed by tissue absorbers, called chromophores. The 
probability of absorption is described by the absorption coefficient, µa, which is defined as 
the probability of absorption per unit length. The absorption coefficient equals the sum of 
all the contributions to absorption by chromophores in the tissue 26, as the following 
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xxa C)10ln(μ ⋅ε⋅=
λλ                                             (2.30) 
 
where λεx is the molar extinction coefficient, and xC is the absorber concentration of the 
chromophore. The product of xx C⋅ε
λ is in units of cm-1. From Eq. (2.30) it is seen that 
absorption coefficient is wavelength depended as a result of different chromophores have 
different absorption spectra. Figure 2.5, shows the absorption spectra of some important 
chromophores in human skin tissue. 
 
 
 
 
Figure 2.5 Absorption spectra of some important chromophores in human skin tissue, as 
function of wavelength. Adapted from Ref27. 
 
 
Constituting 75 % of the tissue, water is the most important absorber in tissue, dominating 
in the UV (λ < 200 nm), and IR (λ > 1300 nm) region28. Other important chromophores in 
tissue are haemoglobin and melanin. The absorption of light by blood depends on the 
oxygenated (HbO2) and deoxygenated (Hb) haemoglobin. The absorption spectra shows 
one sharp peak at about 430 nm for HbO2, while dropping off until 530 nm, the spectra 
picks up at 540 nm and 576 nm, and finally its lowest absorption takes place for 
wavelengths above 600 nm (Figure 2.5). Melanin is a pigment in hair, skin and eye. 
Protecting the organism from UV radiation is the main function of melanin in the skin. 
Melanin absorption decreases with increasing wavelength.  
 
The low-absorbing region between approximately 630 nm and 1300 nm is referred to as 
the tissue optical window. In this range, the penetration of light into biological tissue is at 
its deepest.  
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2.4 Refraction, Reflection29                                        
 
Light incident on a surface of tissue, will be partially reflected and partially transmitted as 
a refracted ray. Due to interaction of light with the medium, the effective speed of light is 
reduced. This reduction is determined by the real part of the refraction index of the 
medium, Eq. (2.18). The real part of the index of refraction is defined as the ratio between 
the speed of light in vacuum and the speed of light in the medium. 
 
v
cn =                                                              (2.31) 
 
The angle relationships for both reflected and refracted light can be derived according to 
Fermat's principle. Fermat's principle says that light follows the path of least time. 
Considering Figure 2.6, the following shows how the law of reflection can be derived 
from the Fermat's principle. The path length L, along the light ray from A to B is  
 
( )2222 xdbxaL −+++=                                           (2.32) 
 
 
 
 
Figure 2.6 Light incidents to the surface of a medium will partially be reflected and 
partially be transmitted (refracted). 
 
 
As the speed of light is constant, we can obtain the point of reflection yielding the 
minimum path distance by setting the derivative of L with respect to x equal to zero 
( 0
dx
dL
= ). 
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which results in 
 
                                     ri sinsin θ=θ   yielding   ri θ=θ                                          (2.34) 
                                                                                                                                          
The above results show the law of reflection. According to the law of reflection, a light ray 
incident upon a reflective surface, will be reflected at an angle equal to the incident angle 
with respect to the normal to the surface. As mentioned in the beginning of this section, 
the index of refraction is defined as the speed of light in vacuum divided by the speed of 
light in the medium, Eq. (2.31); so the index of refraction for different media can be 
measured. Snell's law relates the indices of refraction of the two media to the directions of 
propagation in terms of the angles to the normal. 
 
Considering Figure 2.7, it is seen that Snell's law can also be derived from Fermat's 
principle, by setting the derivative of time equal to zero (n1< n2). 
 
 
                                       
 
Figure 2.7 Light traveling from one medium (n1) into another one (n2) with n1< n2; bends 
toward the normal on the surface leading to Snell's law. 
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Considering the index of refraction defined as 
v
cn = , Snell's law is concluded from the 
last formula (2.37) as 
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In case of unpolarized light, Figure 2.6, the specular reflectance R, which is the fraction of 
the reflected intensity, is given by Fresnel's formula20, 
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For the light reflected in a surface between two media with different index of refraction, 
n1< n2, Snell's law yields that there is a critical angle. Beyond the critical angle, no light 
will be refracted, but 100 % will be reflected. The critical angle for internal reflection for 
light propagation inside tissue, is given by 
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Most biological tissues have an average refractive index ranging 1.38-1.4130,31, except for 
fatty tissues where the refractive index is about 1.46.  
 
In tissue optics, turbid biological media is considered as a collection of discrete randomly 
distributed scattering particles (Figure 2.8). As the index of refraction of these discrete 
elements, ns, is different from that of the surrounding medium, nm; the relative refractive 
index is introduced as the following, 
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Figure 2.8 Scattering by a discrete particle. Adapted from Ref1  
 
 
2.5 Scattering 
 
Light passing through tissue can be attenuated by absorption and by scattering. Only part 
of the light that is transported into the biological tissue will be transmitted. Light 
attenuation in tissue depends on wavelength of the incident light, and the tissue 
Cs 
nm
As 
ns
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characteristics. Tissue absorption was discussed earlier (see section 2.3.2). Here, the 
scattering will be discussed. There are two major types of scattering event. If the 
frequency of the scattered wave is equal to that of the incident wave, it is called elastic 
scattering, but if the frequency of the incident wave and the scattered wave differs, it is 
called inelastic scattering. Rayleigh and Mie scattering are two types of elastic scattering. 
Rayleigh scattering happens when the size of the scatterers (molecules and very tiny 
particles) are much smaller than the wavelength of the incident wave (up to about a tenth 
of the wavelength). Mie scattering predominates when the size of the scatterers are larger 
than the wavelength of the incident light. In Mie scattering the intensity of the scattered 
light increases with shorter wavelength, approximately proportional to 2−λ ; while in 
Rayleigh scattering, it is proportional to 4−λ . It is helpful to consider the molecular 
structure to understand the inelastic scattering event. A molecule is formed by the binding 
of two or more atoms in such a way that the total energy is lower than the sum of the 
energies of the constituents. The description of molecular structure is considerably more 
complicated than that of isolated atoms32 since, apart from energy levels corresponding to 
different electronic arrangements, there are also different states corresponding to 
vibrational and rotational22. The allowed internal energy for molecular structures of 
diatomic molecules is schematically shown in Figure 2.9. 
 
 
 
 
Figure 2.9 Schematic molecular energy level for diatomic molecules, modified from Ref.22. 
 
 
Inelastic scattering happens when the incident light interacts with vibrational and 
rotational levels of molecules causing transition between these levels, and altering the 
wavelength (energy) of the scattered light comparing to the incoming light, see Figure 
2.10. The Raman effect represents inelastic scattering. If the energy of the incident light is 
not corresponding to the energy separation between two electronic levels, still weak 
scattering effects, Rayleigh and Raman scattering, are obtained. As illustrated in Figure 
2.10, depending on the initial and final states, energy of photon is preserved (Rayleigh 
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scattering), increased (Raman Anti-Stokes) decreased (Raman Stokes)33. In quantum 
mechanical theory, virtual levels are introduced, which mediate the scattering22. 
 
 
 
 
Figure 2.10 Raman and Rayleigh scattering. Modified from Ref33. 
 
 
Scattering in tissue is due to several optical effects34; a) reflection and refraction of light 
from interfaces between materials having different refractive indices, b) reflection of light 
by discrete particles in the tissue ranging from organic molecules to whole cells, c) 
absorption of light rays by atoms and molecules and re-radiation at the same wavelength 
but in other directions24. In all these processes just the direction of light changes due to the 
scattering, and no energy loss is involved, so they are under the label elastic scattering.  
  
Scattering in turbid media is described by the scattering coefficient, µs, which is defined as 
the probability of scattering per unit length; and describes the average of how many times 
per unit length a photon change its direction. In tissue, scattering is not isotropic, but 
forward directed35,36.   
 
 
2.5.1 Scattering cross- section, coefficient, and mean free path length 
 
Considering Figure 2.8, the effective scattering cross- section, Cs is defined as 
 
Cs= δs As                                                            (2.42) 
 
where As is the scattering element through the scattering efficiency δs. Hence, the 
scattering coefficient is concluded as  
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where sρ is the volume density of the scattering elements. The average distance a photon 
travels between scattering events, is called the mean free path length, and is defined as 
 
s
s
1pm
μ
=f                                                         (2.44) 
 
 
2.5.2 Scattering phase function and anisotropy factor 
 
In biological tissue the scattering of light is not isotropic, but has been shown to be 
strongly forward directed35,36. Also, neither Rayleigh nor Mie scattering completely 
describe scattering in tissue. Therefore, it is very convenient to define a probability 
function p(θ) of a photon to be scattered by an angle θ, which can be fitted to experimental 
data37. By furthermore assuming that tissue is isotropic in terms of physical properties 
(such as refractive index, density, etc.)38, scattering depends only on the angle θ between 
unit vector directions ŝ and ŝ' (Figure 2.11). The angular dependence of scattering, called 
the probability distribution function and/or the scattering phase function, is a function of 
the scattering angle such that p(ŝ, ŝ') = p(θ).  
 
 
                    
 
 
Figure 2.11 A scattering event causes a deflection at angle θ from the original direction ŝ 
to the direction ŝ'. Adapted from Ref39. 
  
 
For light transport in biological tissue the Henyey-Greenstein function is usually applied 
as the following39,40, 
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such that 
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It is also common practice to express the Henyey-Greenstein function as the function 
of ( )θcosp ; 
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where "g", called anisotropy factor, is the mean cosine of scattering angle θ ( θ= cosg ), 
which measures the degree of anisotropy in scattering. Figure 2.12, shows a series of 
Henyey-Greenstein functions corresponding to different g- values. 
 
 
Figure 2.12 A series of plots of the Henyey-Greenstein functions for different g-values. 
Adapted from Ref40. 
 
 
The g-factor ranges between -1 (for totally back scattering), and 1 (for totally forward 
scattering); while 0g =  corresponds to isotropic scattering. For most biological tissues the 
value of "g" varies between 0.8 and 0.9541. For in vitro tissues in the visible and near- 
infrared wavelength regions, "g" has been measured to be between 0.7 and 0.9938. 
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2.5.3 Mie scattering  
 
Very often, the scattering medium behaves like a collection of discrete spherical particles. 
In this case the Mie scattering, which in its pure form, deals with spherical particles will 
dominate21.  
 
The Mie-scattering theory also called Lorenz-Mie, was developed by Gustav Mie in 1908. 
The theory is named after German physicist Gustav Mie (1868-1957) and Danish physicist 
Ludvig Lorenz (1829-1891), who independently developed the theory of electromagnetic 
plane wave scattering by a dielectric sphere. Mie-scattering theory provides rigorous 
solutions on the basis of electromagnetic theory for light scattering by an isotropic sphere 
embedded in a homogeneous medium19,42. According to Mie theory, the scattering 
properties of non-absorbing homogeneous particle is described in terms of two parameters; 
the magnitude of refractive index mismatch Eq.(2.41), and the size of the surface of 
refractive index mismatch39 as the following, 
 
                           ( )mna2x λπ=                                            (2.49) 
 
which is a dimensionless constant. 
 
In general, when the particle diameter is similar to the light wavelength, light interacts 
with the particle over an effective cross-sectional area larger than the geometrical cross 
section of the particle. The Mie calculation output provides this scattering cross section, 
Cs. Often this parameter is divided by the geometrical cross-sectional area to give a 
dimensionless scattering efficiency parameter; δs (Figure 2.8). 
  
               δs = Cs/Αs                                                   (2.50)  
 
where δs, is the efficiency of scattering, and As = a2 is the true geometrical cross-
sectional area of the particle. The scattering coefficient can be related to the scattering 
number density, ρs, and the cross-sectional area of scattering as, 
 
µs (cm-1) = ρs (cm-3) Cs (cm2)                                 (2.51) 
 
From the mathematical point of view, Mie scattering can be described briefly by 
considering a source, a spherical scattering particle, and an observer whose three positions 
define a plane called the scattering plane. The incident and the scattered light can be 
reduced to their components which are parallel or perpendicular to the scattering plane39, 
see Figure 2.13. As it is seen from the figure, the parallel and perpendicular components 
can be experimentally selected by a linear polarization filter oriented parallel or 
perpendicular to the scattering plane.  
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Figure 2.13 A single scattering event considering the incident and the scattered light 
components. Adapted from Ref39. 
 
The scattering matrix describes the relationship between the incident and scattered electric 
field components perpendicular and parallel to the scattering plane, as the following18 
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The exponential term in Eq. (2.52), which is a transport factor, depends on the distance 
between the scatterer and observer. If one measures scattered light at a constant distance 'r' 
from the scatterer, then the transport factor becomes a constant18. The total field (Etot) 
depends on the incident field (Ei), the scattered field (Es), and the interaction of these 
fields (Eint). In practical experiments, if one observes the scattering from a position, which 
avoids Ei, then both Ei and Eint are zero and only Es is observed. In practical scattering 
measurements, Eq. (2.52) simplifies to the following39, 
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For unpolarized incident light, it can be shown that 
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where S11 is identical to the first element in the so-called Mueller matrix and in this case is 
defined by1 
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2.5.4 Reduced scattering coefficient 
 
An expression for effective scattering in tissue should include both the scattering 
coefficient and the anisotropy factor. The reduced scattering coefficient µs' is a property 
incorporating these factors as the following, 
 
µs' = µs (1-g)                                                    (2.56) 
 
The purpose of µs' is to describe the diffusion of photons in a random walk of step size of 
1/µs', called reduced mean free path length, where each step involves isotropic 
scattering39; 
'
1'pm
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s μ
=f                                                      (2.57) 
Such a description is equivalent to description of photon movement using many small 
steps 1/µs that each involves only a partial deflection angle θ. This way to describe light 
propagation becomes important in cases where there are many scattering events before an 
absorption event, i.e. µa << µs'.  
 
 
 
 
Figure 2.14 The equivalence of 6 small steps of mfp = 1/µs with one mfp' = 1/µs'. 
 
This situation of scattering-dominated light transport is called the diffusion regime and µs' 
is useful in the diffusion regime, which is commonly encountered when visible and near-
infrared light propagates through biological tissues. Figure 2.14 shows the equivalence of 
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taking 6 smaller steps of "mean free path" mfp = 1/µs with anisotropic deflection angles 
and one big step with a "reduced mean free path" mfp' = 1/µs'.  
 
 
2.6 Optical properties of biological media 
 
In general, three photophysical processes affect light propagation in biological tissues: 
refraction, scattering and absorption43. These are defined in forms of refraction index (n), 
scattering coefficient (µs) and absorption coefficient (µa), respectively. Scattering of light 
occurs in media that contains fluctuations in the refractive index (n), whether such 
fluctuations are discrete particles or more continuous variations in (n).  
 
In biomedical optics, scattering of photons is an important event. Scattering provides 
feedback during therapeutic procedures, and has diagnostic values as well. It depends on 
the ultrastructure of a tissue, e.g., the density of lipid membranes in the cells, the size of 
nuclei, the presence of collagen fibers, the status of hydration in the tissue, etc39. 
 
Another important event in biomedical optics is absorption of photons. Absorption is the 
primary event that allows a laser or other light source to cause a potentially therapeutic (or 
damaging) effect on a tissue. Without absorption, there is no energy transfer to the tissue 
and the tissue is left unaffected by the light. It also provides a diagnostic role, as well. 
Absorption can provide a clue as to the chemical composition of a tissue, and serve as a 
mechanism of optical contrast during imaging39. 
 
As stated earlier, scattering and absorption are defined by their coefficients. These 
coefficients are used and investigated as fingerprints in biological optics. While absorption 
coefficient (µa) provides information on the concentration of various chromophores
44, the 
scattering properties provide information on the form, size, and concentration of the 
scattering components in the medium45,46. The scattering properties are divided to 
scattering coefficient (µs), the reduced scattering coefficient (µs'), and anisotropy factor 
(g). The relation between the scattering properties has been shown by Eq. (2.56), earlier.  
 
There are other terms of concerns in tissue optical properties, such as: the total attenuation 
coefficient (µt), and the effective attenuation coefficient (µeff), defined as following, 
 
 
             µt = µa + µs                                                     (2.58) 
 
 
   µeff  = ( )[ ]g1µµµ3 saa −+                                           (2.59) 
 
 
2.6.1 Some biological chromophores and scatterers39 
 
Molecules that absorb light are called chromophores. Depending how light is absorbed, 
these molecules are divided to two types: those that absorb light through electric 
transitions and those that absorb light through vibrational transitions. Electronic transitions 
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are relatively energetic and hence are associated with absorption of UV, VIS, and NIR 
wavelengths. Porphyrins are effective chromophores for absorbing photons. Hemoglobin 
and vitamin B12 are examples of porphyrins in biology. Protoporphyrin IX (PpIX) is one 
of the important factors in PDT (see Chapter 7). The field of infrared spectroscopy, studies 
the variety of bonds, which can resonantly vibrate or twist in response to IR wavelengths 
and thereby absorb such photons. Perhaps the most dominant chromophore in biology, 
which absorbs via vibrational transitions, is water. In the IR region, the absorption of 
water is the strongest contributor to tissue absorption. 
 
About the biological scatteres, it can be said that the light scattered by a tissue has 
interacted with the ultrastructure of the tissue. Tissue ultrastructure extends from 
membranes to membrane aggregates, collagen fibers, nuclei, and cells. Photons are most 
strongly scattered by those structures whose size matches the photon wavelength. 
Scattering of light by structures on the same size scale as the photon wavelength is 
described by Mie theory. Scattering of light by structures much smaller than the photon 
wavelength is called the Rayleigh limit of Mie scattering, or simply Rayleigh scattering. 
Mitochondria, collagen fibers, and fibrils are examples of structures which scatter light in 
biology.  
 
Mitochondria are intracellular organelles about 1 µm in length (variable) which are 
composed of many folded internal lipid membranes called cristae. The basic lipid bilayer 
membrane is about 9 nm in width. The refractive index mismatch between lipid and the 
surrounding aqueous medium causes strong scattering of light. Folding of lipid 
membranes presents larger size lipid structures, which affect longer wavelengths of light. 
The density of lipid/water interfaces within the mitochondria make them especially strong 
scatterers of light. Collagen fibers (about 2-3 µm in diameter) are composed of bundles of 
smaller collagen fibrils about 0.3 µm in diameter (variable). Mie scattering from collagen 
fibers dominates scattering in the infrared wavelength range. About fibrils, it must be said 
that the periodic fluctuations in refractive index on this ultrastructureal level, appear to 
contribute a Rayleigh scattering component that dominates the visible and ultraviolet 
wavelength ranges. 
 
 
  
 
 
 
  
 
 
 
Chapter 3 
 
 
 
 
 
Light transport in tissue 
- theory and models 
 
 
 
                                                                                          Light is life- share it 
                                                                                                        with others. 
                                                                                                  Shri S. C. Pathak 
 
 
 
 
 
3.1 Introduction 
 
When light interacts with biological tissues, different processes can occur. These processes 
depend both on the intensity and wavelength of light and the type of the tissue that light 
interacts with. As it was discussed in the previous chapter, while most of the light enters 
the tissue, a small part of light, depending on the angel of incidence and the index of 
refraction, can be reflected from the tissue surface. Inside the tissue, light interacts with 
the outermost electrons of the molecules; resulting in absorption or scattering. These two 
processes, which are highly wavelength dependent, are the fundamentals of tissue optics. 
From measurements of tissue absorption and scattering-optical properties, physiological 
and structural information about the probed tissue such as the average cell size and shape, 
and the quantity of characteristic tissue biomolecules can be extracted. Light propagation 
in biological medium as multiple scattering medium, is fundamentally governed by the 
Maxwell's equations. However, the electromagnetic theory, in spite of preserving the wave 
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properties of the light, because of the complexity of the mathematical formalism is 
overwhelming; instead, in tissue optics light propagation in turbid media is investigated by 
models based on photon transport. These models are expressed as differential or integro-
differential equations, e.g. the transport equations, which is derived from simple 
phenomenological consideration on the basis of the radiative transport theory1,47. In this 
chapter, the mathematical aspects of light transport in tissue will be discussed.  
 
 
3.2 Propagation of light in tissue 
 
Light propagation in tissue is modeled according to transport theory47. The fundamental 
difference between transport theory and electromagnetic theory is that, while 
electromagnetic theory describes light propagation by superposition of  electromagnetic 
fields, transport theory basically relies on superposition of energy flux, so that the wave 
properties of light (e.g. polarization, interference, and etc.) are not considered in transport 
theory38.  There are on the other hand also similarities between these two theories. For 
example, as it was discussed in the previous chapter, while in electromagnetic theory the 
Poynting vector S expresses the energy transport of electromagnetic waves, in transport 
theory equivalent of S is the flux vector F.  In addition, the radiant power P transferred 
through a surface with the area A in electromagnetic theory,  
 
∫=
A
P S.n dA                                                         (3.1) 
 
can be compare with the power P (J/s = W) transferred through a surface with the area A 
within transport theory, 
                                                                                                                                                  
P ∫=
A
F.n dA                                                        (3.2) 
 
3.2.1 Transport theory 
 
To be able to describe the propagation of light in turbid media, it is essential to explain 
some of the important optical parameters, which are used in modeling of light propagation 
in turbid media. Therefore, the propagation of photons, the radiance, fluence rate, and flux 
are introduced below38. 
 
 
3.2.1.1 Photon distribution function and photon power 
 
The photon distribution function N(r,ŝ), is defined as the number of photons per unit 
volume moving in the direction of unit vector ŝ, in an element of solid angle containing ŝ, 
divided by that element, at a given point r. The power of the photons that propagate 
through the infinitesimal area dA in the infinitesimal solid angle dω in the direction of ŝ, 
with velocity ct, and energy hν (per photon) is defined as 
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                                 dp(r,ŝ) [Js-1= W] =  N(r,ŝ) dA dω ct hν                                        (3.3) 
 
where ct is the velocity of light in tissue (ct =c0/n). Note that dA is perpendicular to ŝ. 
 
 
3.2.1.2 Radiance 
 
In transport theory, light is modeled in terms of the radiance L(r,ŝ) [W/sr], Figure 3.1(a). 
Radiance is the quantity used to describe the propagation of photon power with a certain 
direction ŝ, through a small surface dA, 
 
ω
=
d A
)( p   )L(
d
sˆr,dsˆr,                                                        (3.4) 
 
The radiance can thus be obtained by multiplying the light distribution function with the 
speed of light and energy of the photons in the medium as following, 
 
L(r,ŝ) = N(r,ŝ) 
λ
2
thc                                                    (3.5) 
 
where h is Planck's constant, c the speed of light inside the medium (ct), and λ the 
wavelength of light inside the medium. 
 
 
3.2.1.3 Fluence rate 
 
The Fluence rate Φ(r), is the integral of the radiance over all directions, Figure 3.1(b). In 
biomedical optics, fluence rate is more practical than the radiance itself, as it deals with 
the propagations of photons in all direction. The fluence rate is defined as, 
 
∫
π
ω=Φ
4
)sˆ(r,(r) dL                                                       (3.6) 
 
(r)Φ shows the total power incident on a small sphere at position r, divided by the cross-
sectional area dA of the sphere. 
 
 
3.2.1.4 Net flux 
 
The net flux is defined in terms of radiance as the sum of elemental flux according to 
Figure 3.1(c), 
 
ω= ∫
π
d  L
4
sˆ)sˆ(r,F(r)                                                   (3.7) 
 
  
44 
 
 
 
Figure 3.1 Illustration of incident power P on an area A, described by three important            
optical parameter in transport theory: (a) the radiance L, (b) the fluence rate Φ, and (c) 
the flux F. Modified from Ref1. 
 
 
From Eqs.(3.5) and (3.7), the power incident on the right-hand side of surface A in Figure 
3.1(a), can be calculated as1, 
 
P = ∫ ∫
πA 2
L )sˆ(r, )nˆ.sˆ(  dω dA                                             (3.8) 
 
Medical applications of lasers, often involves light incident on tissue. The amount of light 
can be expressed as the irradiance E0 [W/m2], which is defined as the radiant energy flux 
incident, on an element of the surface, divided by the area of the surface38. A portion of 
this incident light is reflected, and the portion of the beam entering the tissue is attenuated 
by scattering and absorption according to Beer's law, 
 
Φ(d) = E0 (1- R) exp (-(µa- µs) d)                                     (3.9) 
 
where Φ(d) is the fluence rate due to the unscattered beam at position d, E0 is the 
irradiance, and R is the Fresnel surface reflection. The penetration depth is defined 
according to the total attenuation coefficient, µt = µa + µs as, 
 
δ 
tµ
1
=                                                            (3.10) 
 
3.2.1.5 Transport equation 
 
Transport equation consists of different components and terms. In order to describe these 
terms, photons traveling at speed c in direction sˆ  within a small volume dV are 
considered. Conservation of energy yields that photons can only be added to or subtracted 
from the photon distribution function in specific interactions. In this case, the first term of 
A 
n 
F 
A
ds 
L 
A 
n 
L 
ds 
(a) (b) (c) 
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the transport equation, expresses changes in the photon distribution function with time, 
Figure 3.2(a), 
 
( )∫ ∂∂V t
t,sˆr,N  dV                                                  (3.11) 
 
The second term, shows the photons lost through the boundary that can be expressed as a 
surface integral, or by using Gauss' theorem as volume integral, Figure 3.2(b), 
 
( )∫−
S
t,sˆr,N  c dS.sˆ       or      - ∫
V
c sˆ ( )t,sˆr,N∇  dV                    (3.12) 
 
The third term expresses the absorption of incoming photons in the direction sˆ , Figure 
3.2(c), 
 
- ∫ μ
V
a c (r) ( )t,sˆr,N  dV                                             (3.13) 
 
The next term, shows the photons scattering from direction sˆ  into any other direction sˆ ', 
Figure 3.2(d), 
 
- ∫ μ
V
s c (r) ( )t,sˆr,N  dV                                             (3.14) 
 
The fifth term yields the photons gained through scattering from any direction sˆ ' into the 
direction sˆ , Figure 3.2(e) 
 
 
+ ∫ μ
V
s c (r) ∫
π4
 p( sˆ ', sˆ ) ( )t,'sˆr,N  ds' dV                               (3.15) 
 
And the last term expresses the photons gained through a light source "q", Figure 3.2(f), 
 
 
                      +∫
V
q(r, sˆ ,t) dV                                                  (3.16) 
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Figure 3.2 Schematics of the transport equation component terms. (a) The energy of the 
photons in volume V, (b) losses through the boundaries, (c) losses due to absorption, (d) 
losses due to scattering, (e) gain through scattering from any direction to direction sˆ , and 
(f) gain due to a light source within volume V. Modified from Ref1.   
 
Finally, the time-dependent transport equation is presented as following, 
 
 
( )∫ ∂∂V t
t,sˆr,N  dV = - ∫
V
c sˆ ( )t,sˆr,N∇  dV- ∫ μ
V
a c (r) ( )t,sˆr,N  dV- ∫ μ
V
s c (r) ( )t,sˆr,N  dV 
        + ∫ μ
V
s c (r) ∫
π4
 p( sˆ ', sˆ ) ( )t,'sˆr,N  ds' dV +∫
V
q(r, sˆ ,t) dV 
(3.17) 
 
It must be noticed that despite all interactions with the medium, there is no loss or gain in 
photon energy due to the interaction and all the scattering is considered elastic here; in 
short,  the transport equation is derived under the assumption that the energy of the non-
absorbed photons are the same. Another assumption is restricted to monochromatic light 
for this analysis.  
 
Dropping the volume integrals in Eq. (3.17), the time-dependent transport equation is 
obtained as the following; 
 
+∇+
∂
∂ t),sˆ(r,sˆ
t
t),sˆ(r,1 LL
c
( µa + µs) t),sˆ(r,L = µs ∫
π4
t),sˆ(r,L  p( sˆ ', sˆ ) ds' + q t),sˆ(r,  
(3.18) 
 
Now the transport equation has been formulated. The next step is to find its solution. Since 
it is very difficult to solve the transport equation analytically, various numerical and 
approximation methods are employed. These methods are classified in three groups called 
expansion method, probabilistic method, and discretisation method.  
s 
ds 
V 
(a) 
s 
Lout 
 
(f) 
Lout
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S
ds 
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3.2.2 Diffusion theory 
 
According to the expansion method, one way of solving the transport equation is to find 
the solution to its homogeneous part and expand the general solution in terms of the 
obtained homogeneous solution47,48. In diffusion theory, the radiance (L), the phase 
function (p), and the source function (q) of the transport equation Eq. (3.18), are then 
expanded in spherical harmonics. Hence, the expansion of L can be written as, 
 
 L =t),sˆ(r,
π4
1 t)(r,00L
π
+
4
3)sˆ(00Y  t)(r,1m
1
-1m
L∑
=
)sˆ(1mY          (3.19) 
 
By inserting the above expression into the transport equation, Eq. (3.18), and integrating 
over sˆ , the four unknowns L00 and L1m (m = 0, +1,-1) may now be found. Another 
approach is to observe that Y00 is a scalar and that Y1m (m = 0, +1,-1) represent the three 
components of a vector, and thus the radiance can be expressed by them as47 
 
  . B A L sˆt)(r,t)(r,t),sˆ(r, +=                                   (3.20) 
 
According to Eq. (3.20), it is seen that radiance is composed of an isotropic part t)(r, A  
and an anisotropic part  B t)(r, that is the linear gradient of the photon distribution 
function, sˆ  is the vector of gradient. By inserting Eq. (3.20) into Eq. (3.6), the fluence rate 
will be yielded as following, 
 
π=Φ 4t(r, ) t)(r, A                                        (3.21) 
 
Consequently, we may present the net flux, Eq. (3.7) as  
 
    ( )
3
4πt,r =F  t)(r,B                                         (3.22) 
 
Utilizing Eqs. (3.21) and (3.22) in Eq. (3.20), the radiance is expressed as 
 
     L
4π
1t),sˆ(r, = ( +Φ t)(r, 3 ( ) sˆt,r ⋅F )                                 (3.23) 
 
Now, assuming that the light source (q) is isotropic, its expansion into spherical harmonics 
will be 
 
q =t),sˆ(r,
π4
1  q0 t)(r,                                     (3.24) 
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Finally, considering all the expanded term, the transport equation can be written as the 
following, 
 
 
t
1
∂
∂
c
( +Φ t)(r, 3 ( ) sˆt,r ⋅F ) = - sˆ .∇ ( +Φ t)(r, 3 sˆ t).(r,F ) - (µa+µs) ( +Φ t)(r, 3 sˆ t).(r,F ) +  
                                             µs ∫
π4
 p( sˆ ', sˆ ) ( +Φ t)(r, 3 sˆ t).(r,F ) ds' + q0 t)(r,  
(3.25) 
 
Considering the scattering phase function, and applying Eqs. (3.23) and (3.24); Eq. (3.25) 
is reduced to  
 
t
1
∂
∂
c
( +Φ t)(r, 3 sˆ t).(r,F ) = - ( sˆ .∇ + µa)Φ (r,t) - 3 ( sˆ .∇ + µa + µs') F (r,t). sˆ  + q0 (r,t) 
(3.26) 
 
Integrating this expression over sˆ  results in 
 
 
c
1
t
t)(r, 
∂
Φ∂ = - µa t)(r, Φ  - ∇ . F (r,t) + q0 (r,t)                             (3.27) 
 
On the other hand, if Eq. (3.26) is multiplied by sˆ  and then the integration is carried out, it 
results in 
 
c
1
t
t)(r,
∂
∂  F = 
3
1 ∇ t)(r, Φ - (µa + µs') F (r,t)                                (3.28) 
 
The last two expressions, Eqs. (3.27) and (3.28), are the basic equations of diffusion 
theory. By eliminating the dependent variable F, these two equations can be reduced to 
one equation. The steady-state solution of Eq. (3.28) presents Fick's law, 
 
 
F (r,t) = - D(r)∇ t)(r, Φ                                               (3.29) 
 
where the diffusion coefficient D is introduced as, 
 
D(r) = ( )'μμ3
1
sa +
                                                  (3.30) 
 
Finally, from the last two equations, Fick's law and the diffusion coefficient expression, 
the time-dependent diffusion equation is obtained as the following, 
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c
1
t
t)(r, 
∂
Φ∂ - D(r) 2∇ t)(r, Φ  + µa t)(r, Φ  = q0 (r,t)                              (3.31) 
 
It must be noticed that the diffusion equation is valid only if the propagating light is 
diffused, and this implies that the reduced scattering coefficient is much larger than the 
absorption, i.e. 
 
µs´ >> µa                                                                                   (3.32) 
 
The other point is that the source and detector must be separated in space and time to 
allow that the light is diffused when it reaches the detector. It has been shown that 
diffusion theory is inaccurate in applications that involve structures near the surface of the 
medium, small source-detector distances, and geometrical configurations with sharp 
discontinuities of the scattering properties1,49. 
  
 
3.2.2.1 Time- domain and point source solutions 
 
For an infinite homogeneous medium or a medium with simple boundary conditions, and 
with a short pulse isotropic point source, i.e.  
 
q0 (r,t)= δ (0,0)                                                   (3.33) 
 
where δ  is Dirac’s delta function; the solution to the diffusion equation is a Green’s 
function expressed as50, 
 
t)(r, Φ  = Qs c (4π Dct )-3/2 exp ( ctμt4D
r
a
2
−−
c
)                        (3.34) 
 
where Qs  is the energy of the short pulse from the point source at (t = 0) and "r" is the 
radial distance from the source. 
 
When illuminating a small spot on the tissue surface, the source function cannot be 
described by an isotropic point source. In this case a line source consisting of isotropic 
point sources with an exponentially decay strength, proportional to exp [- (µa+µs´) z] is 
used; where "z" is the distance from the boundary. Thus, the fluence rate can be calculated 
from an integral of Green’s function for sources at all depths. Assuming that all the 
incident photons are initially scattered at a depth equal to the mean free path (z = 1/µs´), 
simplifies the case for isotropic scattering, Figure 3.3. Here, source can be approximated 
with the simple delta-function, as the following50,51, 
                                                                             
 
q0 (r,t)= δ (r-r0) δ (t)                                             (3.35) 
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Figure 3.3 Schematics of the two possible representations of the source. (a) A continuous 
line of sources with an exponential decay, and (b) the source at a depth of z = 1/µs’, 
represented by delta function. Modified from Ref50. 
 
 
The boundary conditions must be considered in solving diffusion equation for anything 
else than for an infinite medium. It means that, if the refractive indices are matched, the 
physical requirement is that there should be no photon flux back into the turbid medium at 
the surface. A good approximation is to introduce a virtual, or extrapolated boundary 
(z=ze), and there apply Φ  = 052. For index matching, one can derive the value ze ≈ 2D19. 
In index mismatched, i.e. when the tissue and the surrounding medium do not have the 
same refractive index, this distance will change; because of an internal reflection at the 
boundary52,53. For n = 1.4, an extrapolated boundary at ze ≈ 5.5D is appropriate. The 
method of images or negative mirror sources, is introduced to set the fluence to zero at the 
extrapolated boundary53. As it is shown in Figure 3.4, the point source z = z0, is mirrored 
in z = -ze, resulting in a negative source at z = - (2ze + z0). 
 
 
It should be noticed that when the observation of the radiance is made at a distance from 
the source that is considerably larger than the extrapolated boundary length, the zero 
radiance at the physical boundary is a valid approximation; but at too short distances, the 
diffusion approximation is not valid. 
 
Now, the simple solutions for a semi-infinite homogeneous geometry can be derived. The 
time resolved diffuse reflectance is expressed as the following 51 
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 z
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(a) (b) 
   z0 
z 
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- 
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r 
   
R (r) 
Figure 3.4 Schematic picture showing the 
  principle of an extrapolated boundary at 
 z = -ze , with 
Φ
 = 0. A dipole source is 
placed symmetrically around the extrapo-
lated boundary, with a positive part at z = 
z0, inside the medium, and a negative part 
at z = - (2ze + z0). 
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(3.36) 
 
The corresponding steady-state diffuse reflectance is expressed as 
 
R(r) = 
( ) ( ) ( )⎥⎦
⎤⎢⎣
⎡ μ−
⎟⎟⎠
⎞
⎜⎜⎝
⎛
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⎛
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π 22
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2
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1
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r
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r
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r
1z
4
1   
                                                    (3.37) 
 
where 
 
D
a
eff
μ
=μ  , 2201 rzr +=  , ( ) 22e02 rz2zr ++=  , '
1z
s
0 μ
= , 0e bzz ≈        (3.38) 
 
Here, "b" is dependent on the actual Fresnel reflection coefficient, for example, b = 2 for a 
typical tissue-air boundary1. 
 
The total diffuse transmitted light through a homogeneous slab, detected on the side 
opposite to the source, will then is written as the following, 
 
                T (d, t) = ( ) ( )×−π −− tμexptD4 a2321 cc  
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                     (3.39) 
 
where "d" is the thickness of the slab. Fitting the analytical solutions of Eqs. (3.36) and 
(3.39) to a measured reflectance or transmittance curve, will provide an estimate of optical 
properties µa and µs'. The g-value can never be evaluated with diffusion theory. 
 
 
3.2.2.2 Frequency domain solutions 
 
In frequency domain, instead of pulsed light source, a sinusoidal modulated light source 
with frequency f, is used to launch photons into the tissue38. The source fluence rate has 
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two components; AC ( 0Φ ) and DC ( 1Φ ). In this way, photon density waves are 
generated. These propagate in the tissue with fast decaying DC and AC amplitudes. The 
net fluence rate which describes the photon density wave initiated by a point source within 
an infinite homogeneous medium, can be written as53,54 
 
                             Φ  (r,t) = DC (r) + AC (r) exp[i(ki- ωt)] 
          
           = Φ 0 
( )
+
−
r
rμexp eff  ( )
r
rexp  rk−  exp [i(ki r - ωt)]                (3.40) 
 
where  
 
µeff  = 
2
1
a
D
⎟⎠
⎞⎜⎝
⎛μ
= ( )( ) 21saa 'μμ3μ +                                       (3.41) 
 
In comparison between light propagation in time domain and in frequency domain it can 
be said that in applying short pulse to a scattering medium, this pulse is broadened in time 
due to propagating to many paths between source and detector. Then, the observed 
quantity is the number of photons reaching the detector per unit time at a given time, h(t). 
However, in frequency domain, applying the sinusoidially modulated light source, the 
observed quantity at the detector, are the phase angle between the detector and the source, 
and the amplitude of the oscillation relative to the DC level. In this case, the photon flux at 
the detector will be sinusoidal in time but the oscillation will be delayed in time relative to 
the source and reduced in amplitude relative to the average flux. The time domain signal 
h(t) is linked to the modulation and phase by Fourier transformation so that any 
information obtained in the time domain can be obtained in the frequency domain, as 
well38. However, there are a few advantages of using frequency domain rather than time 
domain sources such as narrow band and noise resistant measurements in frequency 
domain measurements. 
 
 
3.2.3 Monte Carlo simulations 
 
In Monte Carlo (MC) technique, every simulation is based upon events that happen 
randomly, and so the outcome of a calculation is not always absolutely predictable. This 
element of chance reminds one of gambling, so the originators of the Monte Carlo 
technique, Ulam and von Neumann, called the technique Monte Carlo to emphasize its 
gaming aspect. MC simulations can be used for simulating all kinds of particle transport. It 
has mainly been developed for neutron transport in combination with nuclear reactions. 
 
In tissue optics, Monte Carlo (MC) modeling is used as a technique for describing light 
transport in tissue, based on the transport equation and the random walk of photons in 
absorbing and scattering medium. In this case, the photons are considered as neutral 
particles and all wave phenomena are neglected. 
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In MC simulation, a photon package is traced through the tissue until it exits or is 
terminated due to absorption. Many physical parameters of the photon package such as the 
distribution of absorption, exiting position, time-of-flight, etc can be logged. By repeating 
the tracking process for a large number of photon packages, it is possible to obtain 
statistics for these physical quantities. In MC simulations, the key decisions are the mean 
free path for scattering or absorption event, and the scattering angle, see Figure 3.5(a). The 
number of photons needed depends on the problem and the wanted accuracy. Another 
aspect of the MC simulations is that they are based on macroscopic optical properties (µa, 
µs, and g) that are assumed to extend uniformly over small units of tissue. 
 
The main advantage of MC method is that there is no limitation concerning boundary 
conditions or spatial localization of inhomogeneties in the tissue. On the other hand, the 
main drawback of MC is the problem of getting good statistics, particularly if the point of 
interest is located far away from the point of entry of the light and the scattering and 
absorption coefficients are high. For sampling the random variable x in MC simulation, a 
probability density p(x) is considered, which defines x over the interval bxa ≤≤ such 
that: 
 
1dx)x(p
b
a
=∫                                                       (3.42) 
 
The probability that x will fall in the interval [a, x] is given by the distribution function 
Fx(x1) as the following, 
 
( ) ( )dxxpxF 1
x
a
1x ∫=                                                  (3.43) 
 
By using a random number generator, one can obtain a random number ζ in the range of 
[0, 1]. The probability density function for this random number is 1 in the range [0, 1], and 
the corresponding probability distribution is as the following, 
 
( ) ( ) 1
a
1 dpF
1
ζ=ζζ=ζ ∫
ζ
ζ    ,    10 1 ≤ζ≤                                   (3.44) 
 
This means that the picked random number gives the integrated value of p(x), which is the 
basic equation for sampling random variables from non-uniform distribution using 
uniformly distributed random number55. This equation is defined as 
 
( ) ( )dxxpxF 1
x
a
x ∫==ζ                                               (3.45) 
 
This sampling principle in MC simulation is illustrated in Figure 3.6.  
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Figure 3.5 Schematic of Monte Carlo simulations showing (a) random walks of multiple 
photons, and (b) the basic stochastic parameters governing the photon migration, i.e. step 
size s, scattering angle θ, and azimuth angle Ψ. Modified from Ref1. 
 
The free path length of the photon between two interactions, called step size, is calculated 
based on the sampling probability for the interactions. From the probability for absorption, 
µa ds, and the probability for scattering. µs ds, the probability for any interaction is given 
by (µa+µs) ds. Therefore, the probability density function of the step size "s", (s∈  [0, ∞ ]), 
is defined accordingly as the following, 
 
ps = ( ) ( )ssµaµ- e µµ sa ++                                            (3.46) 
 
 
 
 
 
Figure 3.6 Schematic of sampling of a random variable from a non-uniform distribution. 
The arrows show the mapping from the probability density function p (ζ), via the 
distribution function Fζ(ζ) and Fx(x), to the probability density function p(x). The shaded 
areas are equal, but shown in different scale38,55. 
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From Eqs. (3.45) and (3.46), the step size, shown in Figure 3.5(b), can randomly be 
sampled as the following 
 
( )
( )sa µµ
lns
+
ζ
=
-                                                       (3.47) 
 
The scattering deflection angle θ is sampled from the Henyey-Greenstein distribution, 
within [0, π ]. For convenience, µ = cos(θ) with µ distribution in the interval [-1, 1] is 
considered. Taking each step, photon looses a fraction of its energy due to the absorption. 
This can be described in form of the deposited energy ( QΔ ) as the following, 
 
                                                             QΔ = W 
t
a
µ
µ
                                                      (3.48)  
 
where W is the photon weight. The new photon weight,  ,WΔ  is given by 
 
WΔ = W 
t
s
µ
µ                                                       (3.49) 
 
Note that ( QΔ +  WΔ = W ) equals unity, so energy is conserved. 
 
Now, the weight of the photon is reduced by W,Δ  and the deflecting angle, θ∈[0, π ], can 
be sampled by considering (µ = cosθ) for convenience, as the following, 
 
 
cosθ = ⎟⎟⎠
⎞
⎜⎜⎝
⎛
⎟⎟⎠
⎞
⎜⎜⎝
⎛
ζ+−
−
−+
g2g1
g1g1
g2
1 22       for      g ≠ 0 
 
, and 
 
 
cosθ = 12 −ζ       for      g = 0 
 (3.50) 
 
For Mie scattering the Henyey- Greenstein (HG) which is a good approximation for the 
probability density function, is sampled as 
 
p (µ) ( ) 232
2
µg2g12
g1
−+
−
=                                            (3.51) 
 
The HG approximation implies symmetric scattering around the direction of propagation, 
in other words, the azimuthal angle, Ψ, is uniformly distributed within the interval [0, 2 π ].  
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Thus, Ψ, is sampled as the following, 
 
Ψ ζπ=    2                                                           (3.52) 
 
For each step one has to check if the photon package crosses an internal or external 
boundary. If this is the case, the reflection and/ or escape must be checked by utilizing the 
Snell and Fresnel laws. The escaped fraction adds to the result file and reduces the left 
weight of the photon package. After a certain number of scattering events, the remaining 
photon package weight will be low. Thus, by applying a technique called roulette, an 
efficient MC code is to use. This technique gives a package a chance of m of surviving 
with a weight mW; otherwise the weight is reduced to zero and the package is terminated. 
This cycle of calculations repeatedly continues until the photon leaves the medium or 
terminated.  
 
As already discussed, in MC simulations, results can be recorded as absorbed, reflected, or 
transmitted fraction. These functions can be recorded as a function of position, trajectory 
direction, and time.  
 
Computer code for MC simulations is written using the guidelines above. A standard MC 
program for MC simulation in the filed of tissue optics for Multi-Layered media, MCML, 
written by Jacques and Wang, is well known56,57. This program is written in C. All 
simulations performed in this thesis were don using codes based on MCML.  
 
As it was explained already, the MC method has been widely used to solve radiative 
transfer problems due to its flexibility and simplicity in simulating the energy transport 
process in arbitrary geometries with complex boundary conditions. However, the major 
drawback of the conventional (or forward) Monte Carlo method (FMC) is the long 
computational time for converged solution. Reverse or backward Monte Carlo (RMC) is 
considered as an alternative approach when solutions are only needed at certain locations 
and time. The reverse algorithm is similar to the conventional method, except that the 
energy bundle (photons ensemble) is tracked in a time reversal manner. Its migration is 
recorded from the detector into the participating medium, rather than from the source to 
the detector as in the conventional MC. There is no need to keep track of the bundles that 
do not reach a particular detector. Thus, RMC method takes up much less computation 
time than the conventional MC method. On the other hand, RMC will generate less 
information about the transport process as only the information at the specified locations, 
e.g., detectors, is obtained.  
 
In the situation where detailed information of radiative transport across the media is 
needed the RMC may not be appropriate. RMC algorithm is most suitable for diagnostic 
applications where inverse analysis is required, e.g., optical imaging and remote sensing58. 
Figure 3.7, shows the schematics of forward and reveres MC. As it is seen from this 
figure, the main discrepancies are expected at the interface between two layers with 
different refractive indices. 
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Figure 3.7 Schematic of the two types of Monte Carlo simulations, (a) Forward MC, and 
(b) reverse MC 
 
 
3.2.4 The adding-doubling method 
 
The adding-doubling (A-D) method is another way for solving the radiative transport 
equation, with accurate solution for anisotropic scattering and mismatched boundaries 
with arbitrary sample thiknesses59. It yields angle-dependent reflection and transmission 
readily, while especially reflectance is important for diagnostic applications using light. 
The general idea of A-D method is that, it assumes knowledge of the reflection and 
transmission properties for a single thin homogeneous layer; then, the reflection and 
transmission for an arbitrary thick slab are obtained by repeatedly doubling until the 
desired thickness is reached. The adding method extends the doubling method to 
dissimilar slabs, thereby allowing one to simulate different layers and/ or internal 
reflection at boundaries60. The main disadvantages of this method are that it is (a) 
restricted to layered geometries with uniform irradiation, and (b) necessary that each layer 
have homogeneous optical properties. 
 
The inverse adding-doubling (IAD) is also another method for generating the optical 
properties of turbid media. Reflection and transmission measurements, typically made 
with an integrating sphere (see Chapter 4), are converted to the optical properties of the 
sample using a computer program. The IAD model, finds the optical properties 
characterizing a sample by using reflection and transmission measurements. A set of 
optical properties is guessed and the reflection and transmission is calculated. These 
values are compared with the measured reflection and transmission values. If they match 
then the optical properties for the sample have been found. If they do not match then a 
new set of optical properties is guessed and the process is repeated61.  
 
 
3.3 Polynomial regression 
 
Although analytical expressions for R (µa, ,µs, g) and T (µa, µs, g) are provided by 
different methods such as diffusion theory62, the inverse problem of determining µa (R,T) 
and µs (R,T), has no analytical solutions
63. Furthermore, the analytical solutions of R (µa, 
µs) and T (µa, µs) are not accurate; thus most contemporary approaches are based on 
numerical methods, which provide more accurate calculations of R (µa, µs) and T (µa, µs), 
Source 
Collection Source 
Collection ≈
(a) (b) 
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e.g., the inverse adding–doubling (IAD) or methods involving Monte Carlo 
simulations15,63. For all the above methods it is common that µa (R, T) and µs (R, T) have 
to be determined by iterative numerical calculations. This may prove to be too slow in 
some cases. So, the inverse problem can be solved using a fast root solver. In Papers I, II 
and V, this method has been employed. A pre-computed result was generated, yielding 
maps of R and T as functions of µs' and µa. The Monte Carlo data were then fitted to an 
expansion of Chebyshev polynomials with least-squares regression, according to Eq. 
(3.53). Chebyshev polynomials form a complete orthogonal function set and are thus 
suited for this kind of expansion55, see Figure 3.8. 
 
 
P (µa, µs', m) = (a0 + a1 µa + a2 µa2 + ... + am µam) ×                                 (3.53) 
                                         (b0 + b1 µs' + b2 µs' 2 + ... + bm µs' m) 
 
 
where (a0, a1, a2, ...and b0, b1, b2, ...) are fitting coefficients determined by least-squares 
regression, and m is the order of the  double polynomial. The resulting polynomials fit to 
simulated R (Rsim) and simulated T (Tsim), were defined as
63  
 
 
Rfit = PR (µa, µs', m) 
 
Tfit = PT (µa, µs', m)                                               (3.54) 
 
 
To solve the inverse problem of extracting the optical properties from the measured 
values, it means Rmeas and Tmeas, new polynomials are formed, as the following,  
 
 
F (µa, µs') = Rfit - Rmeas 
 
G (µa, µs') = Tfit - Tmeas                                                     (3.55) 
 
 
The solution is obtained by finding the common roots of the polynomial equations formed 
by setting these polynomials equal to zero55. A Newton-Raphson algorithm was used for 
this purpose. 
 
  
59
 
 
 
Figure 3.8 Polynomial regressions for Monte Carlo data to solve the inverse problem for 
integrating sphere measurements. (a) Monte Carlo computed data for R and T, (b) the 
corresponding fitted polynomials; (c) and (d) show the relative error between the Monte 
Carlo data and the polynomials for T and R, respectively.  
 
 
3.4 Tissue phantoms 
 
Usually, in order to validate the light propagation models, and also for calibrating and 
testing the validation of the systems used for measuring the optical properties; artificial 
samples are needed. This artificial samples, called tissue phantoms, must be easy to make 
and shape; and must be stable and reproducible to be trusted to use for calibration and 
validation purposes. Also, they should be matched with the optical properties in terms of 
scattering coefficient (µs'), absorption coefficient (µa), anisotropy factor (g), and refractive 
index (n), over the entire spectral range of interest55,64. There are many different tissue 
phantoms from liquid to hard forms, but most of them are either water or resins based. 
Epoxy is one of the most common materials used as a hardener to make solid phantoms. 
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3.4.1 Water-based phantoms 
 
Ordinary milk is the simplest phantom material. The scatter contents of milk are the fat 
droplets and proteins suspended in the water55,65. The only absorber in pure milk is water, 
which considering Figure 2.5, it has very low absorption in the visible spectrum; and starts 
increasing the absorption when approaches the NIR region. However, by adding dyes or 
ink into milk, absorption can be obtained in other parts of the spectrum. Relatively high 
absorption of water at 970 nm, is a problem in using milk as water-based phantom, if the 
measurements over 900 nm are to be done55. The main problem of using milk as a 
phantom material is that milk does not have well defined optical properties, and it also can 
not be verified by theory. Instead, another material, called Intralipid or Nutralipid, which 
is a suspension of lipid particles, is used most often in investigations, as tissue 
phantom63,66-68. Intralipid which  is very similar to milk in composition, has a long and 
glorious history of being measured, and also is used clinically as an intravenously 
administered nutrient, and in research provides the scattering component in a tissue 
phantom to investigate the propagation of light in tissue 69. In Papers II, and V, different 
concentrations of intralipid, providing different scattering coefficients have been used.  
 
However, there are advantages and disadvantages of using intralipid for making tissue 
phantoms. The quality of the intralipid can be controlled, and as it is sterile, it can be kept 
longer, but still its optical properties are not particularly well defined55. On the other hand, 
intralipid it is a food substance and not an optical medium. Consequently, no effort has 
been made to make all bottles of intralipid optically equal. Moreover, it seems that the 
optical properties of a bottle of intralipid change over time. Experiments show that a 
variation in order of 20 % can be seen from the values Van Staveren et al. are predicting 
for intralipid-10 %69. One must be careful in choosing absorber to add to the phantoms, as 
some absorbers changes the scattering properties of the phantoms. In general, acidic dyes 
can cause the fat emulsion of the intralipid to split55. Some of the dyes used as absorber, 
are: food dyes (in the visible region), carbon-based inks (in the NIR), inks, and etc. 
 
 
3.4.1.1 Polystyrene microspheres 
 
Suspension of monodisperse microspheres is the best water-based phantoms, but 
expensive ones. Apart from the possibilities of keeping the microsphere suspension longer 
than the intralipid ones, the main advantage of using this type of phantoms is that as the 
size of the scattering spheres is known, it is possible to do the Mie calculation for the 
scattering properties, and hence the g-value can be controlled55. Microsphere suspensions 
have been used in an investigation not presented in this book, when a comparison between 
optical properties measurement with IS method and optical coherence tomography method 
was performed.  
 
 
3.4.2 Resin phantoms 
 
Plastics phantoms are stable and reproducible, on the other hand as solid phantoms it is 
possible to make them in different shapes and embedded inhomogeneities, but making 
them is complicated and once it has been set, there is no possibility to alter their 
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properties. Curing plastics such as polyester and epoxy resins are commonly used in 
laboratories as phantom materials, since the scattering and absorbing agents can easily be 
mixed with the liquid resin. In Paper I, the phantoms used for the investigation were made 
of epoxy resin with an aliphatic amine as hardener, and TiO2 powder as scatterer.  
 
 
3.4.3 Refractive index 
 
Usually, the main contents of tissue phantoms are either water or resin. The real tissue 
refractive index is n = 1.4, while for water and resin is 1.33 and 1.55, respectively. For 
validation purposes, these differences may not be of concern, since a model that is 
accurate for each one, is likely to be so for the other one. However, for calibration 
purposes, this might be needed to be taken under consideration55. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Chapter 4 
 
 
 
 
 
Measurement of tissue optical properties 
- methods & instrumentation  
 
 
 
You see things; and you say, "Why? 
" But I dream things that never were; 
 and I say "Why not?" 
 
                                                                                             George Bernard Shaw 
 
 
 
 
 
 
4.1 Introduction 
 
As it was described already, the propagation of light in a medium is described by its 
optical properties. The fundamental optical properties of interest are the absorption 
coefficient, µa, scattering coefficient, µs, total attenuation coefficient, µt, scattering 
anisotropy, g, reduced scattering coefficient, µs', effective attenuation coefficient, µeff, and 
the tissue refractive index, n 70. One way to classify the techniques for measuring optical 
properties, is to divide them into in vivo and in vitro methods. Another way of 
classification is to divide the techniques into direct and indirect methods. The direct one 
refers to measuring a particular microscopic coefficient, independent of any light 
propagation model in tissue, such as diffusion approximation or adding-doubling model. 
Indirect methods involve, on the other hand, derivation of the optical properties from 
results of e.g. reflection or transmission measurements by solving an inverse problem. In 
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inverse problems, the optical properties can be obtained by an iteration algorithm. Values 
of optical properties are guessed and inserted in a light propagation model, and then 
reflection and transmission values are computed, so that the optical properties are adjusted 
until the computed reflection and transmission values are matching the measured ones71,72. 
All these techniques, can be further sub-divided in three major divisions called, one-
parameter, two-parameter, and three-parameter techniques. 
 
 
4.2 One-parameter techniques 
 
In this technique, the number of possible unknowns is N=1, meaning that only one of the 
tissue optical properties is derived. The narrow-beam method, illustrated in Figure 4.1, is 
such a technique. Here the fraction of light passing straight through an optically thin 
sample without interacting is measured. The signal is called the collimated transmittance15. 
The total attenuation coefficient, µt = µa + µs, can thus be obtained by using the Beer-
Lambertian law, Eq. (4.1).  
 
( )dµexp t−= 0I  I                                                       (4.1) 
 
Figure 4.1, shows the schematic set-up for narrow beam transmission measuring, using a 
collimated detector73,74.  
 
 
Figure 4.1 Schematic of narrow beam set-up. 
 
Here, the validity of the derivation of µt is critically dependent on how true the assumption 
that the detected scattered light is negligible compared with the detected unscattered light 
is. Two experimental factors affect this assumption: one is the collection angle θc of the 
detector, and the other is the scattering optical depth µsd of the sample. The collection 
angle determines the percentage of scattered photons collected by the detector, while the 
scattering optical depth determines the number of scattered photons compared with the 
unscattered photons75. This measurement is thus suitable for optically thin samples only. 
For optically thick samples, this measurement provides interesting data, only if the 
multiple scattered light is prevented from reaching the detector. This can be assured by 
providing a large distance between the sample and detector and utilizing small apertures in 
front of the detector15. In narrow-beam measurement, the relative error of the 
measurements increases non-linearly with sample thickness and scattering coefficient. The 
Optical fiber 
Sample 
Pin-hole 
Detector 
d 
θc 
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measurements include recording a beam passing through the tissue, as well as an 
unattenuated beam, yielding a reference measurement. The limitations posed by the 
limited dynamic range in the detection can be overcome by using calibrated neutral 
density filters in the light path for the reference measurement. In addition, the scattered 
light intensity can be reduced by placing two polarizing filters with parallel polarization 
axes before and after the sample76,77.  
 
 
4.3 Two-parameter techniques 
 
In two parameter methods in this field, the unknowns are usually the reduced scattering 
(µs') and absorption (µa) coefficients. It is frequently impossible to measure µs by the 
methods under this category. As these methods often apply to dense tissues, the advantage 
is the possibility to perform in vivo measurements. The two-parameter methods are 
typically based on measurements of the diffuse reflectance or transmittance from the 
medium. To extract the optical properties, these measured quantities are followed by 
inverse computation and fitting procedures, which have been described above. In two-
parameter techniques, the measured diffuse reflectance or transmittance of medium can be 
analyzed with three different methods; spatially-, time-, and frequency-resolved methods. 
The concepts of those are shown in Figure 4.2.  
 
 
 
 
 
Figure 4.2 The principles of the three different two-parameter techniques: (a) CW 
spatially resolved reflectance measurements, (b) time-resolved measurement by injecting a 
short pulse and measuring the temporal point-spread function (either reflectance or 
transmittance mode), and (c) frequency-modulated measurement (either reflectance or 
transmittance mode). In (c), the phase shift φ and the modulation depth, (C/D)/ (A/B), are 
measured. Modified from Ref55. 
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4.3.1 Spatially resolved techniques 
 
In this technique, as it has been illustrated in Figure 4.2(a), the diffused reflected 
continuous wave (CW) is monitored as a function of its distance from the incident beam. 
The evaluation is normally done by fitting the measured R(r) to the solution of the 
diffusion equation. In this technique, the light probes somewhat different volumes and at 
slightly different depths depending on the distance from the light source, see Figure 4.3. 
 
 
 
 
Figure 4.3 The CW reflectance for different source-detector distances. 
 
 
In Figure 4.3, the shape of the radial, which depends on the reflection, is determined by 
the optical properties of the tissue. Hence, in highly scattering tissue, photons will have 
longer propagation before they are detected; higher reflectance in the reflectance pattern is 
yielded. Therefore, in the tissue with higher scattering properties, great reflectance over 
the entire radial range is produced. Moreover, a very isotropically scattering tissue, results 
in higher reflectance close to the center. The reduced scattering coefficient and the 
absorption coefficient can be obtained from analytical fitting expression generated by the 
diffusion equation52,78,79, and also Monte Carlo method80,81 Although, since the 
measurements are performed close to the light source; the diffusion equation might not be 
an ideal model for the light transport.  There are advantages and disadvantages of using 
spatially resolved technique for extracting optical properties. Small, portable and 
inexpensive instrumentation together with possibility of performing measurements on 
patients in vivo, are the main advantages of this technique, while sensitivity of this method 
to inhomogeneities in tissue together with the limitation of measurements for deep 
structures inside the medium, are the main drawbacks. 
 
 
4.3.2 Time-resolved techniques 
 
In time-resolved measurements, a combination of short pulse light source (picoseconds) 
and a fast detector is employed. As it is schematically shown in Figure 4.2(b), the 
temporal behavior of the diffuse reflected pulse is detected at some distance from the 
incident light. The optical properties can be evaluated by fitting the solution of the 
diffusion equation to the result of a measurement. Alternatively, time-resolved Monte 
Carlo simulations, can also be employed in the data analysis15,82,83. In time-resolved 
method, the shape of the detected signal is more important than its absolute intensity; 
because the shape of the signal is characteristically influenced by the optical properties of 
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the medium51,84-86. It means that, the absorption coefficient (µa) affects the final slope of 
the attenuation curve, while the early part of the curve is practically invariant of µa. The 
reduced scattering coefficient (µs'), on the other hand, does not affect the final slope to any 
higher degree, but only the early part of the curve. The scattering increases the effective 
path length of light in tissue, meaning that an increase in scattering coefficient will 
effectively shift the peak of the time-resolved curve towards longer recording times.  
 
In comparing the time-resolved and the spatially resolved techniques, it can be said that 
time-resolved measurements is relatively less sensitive to small inhomogeneities. This 
gives an advantage for in vivo measurements on patients. The main disadvantage of this 
technique is the relatively complicated and expensive instrumentation required. 
 
 
4.3.3 Frequency-resolved techniques 
 
In this technique a sinusoidally amplitude-modulated source is used to launch photons into 
the tissue rather than a pulsed light source used for time-resolved measurements26. In this 
way, a photon density wave, associated with a certain phase velocity, is propagating in 
tissue15. As can be seen in Figure 4.2(c), the amplitude modulation ( ))( /)( A/B C/D , 
decreases and the phase φ shifts when the light propagates in tissue. These changes are due 
to the absorption and the scattering properties of tissue. A Fourier transformation of the 
time-resolved diffusion equation, links the measurements to µs' and µa
87. With constant 
source-detector distance and modulation frequency, it can be shown that a decreasing 
absorption coefficient or increasing effective scattering coefficient, results in a larger 
phase shift and weaker modulation15,54,87,88.  
 
 
4.4 Three-parameter techniques 
 
The most frequently used method of measuring optical properties of small tissue volumes 
is the integrating sphere (IS) technique. This method is used to probe a thin slice of 
excised tissue 89. It can be employed as either a three-parameter technique for extracting 
µa, µs, and g from measured total diffused reflectance (Rtot), total diffused transmittance 
(Ttot) and collimated transmittance (Tcol), or as a two-parameter technique for measuring 
µa and µs' from the recorded values of Rtot and Ttot
90. The technique has been shown to 
provide relatively accurate results for tissue phantoms63. It can, however, be debated how 
much the optical properties of tissues are affected by tissue excision and sample 
preparation. 
 
 
4.4.1 The integrating sphere method 
 
According to S. Prahl (1999), there is a long history of the use of integrating spheres. 
Good 'ole Ulbrecht reported the first one a hundred years ago. Utilizing an integrating 
sphere (IS) method, measurements of the total and collimated transmittance as well as 
diffuse reflectance, can be conducted. The sphere has an inner surface covered by highly 
reflecting barium sulphate. Light transmitted through a thin tissue sample (around 1mm 
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for biological tissue) when placed at entrance port, facing the light source, is scattered in 
the highly scattering surface of the sphere until reaching the detector. Similarily, the 
diffusely reflected light flux is measured by placing the tissue sample at the exit port of the 
sphere. The scattering by the integrating sphere transfers the transmitted and reflected light 
to diffuse light fluxes, being independent of its initial direction, and thus allows it to be 
probed by the detector with the same sensitivity independent on the direction of the light 
as it escapes the tissue sample. The detector may consist of an optical fiber or bundle 
guiding the collected light to a spectrometer to allow simultaneous measurements in a 
broad wavelength-range, see Figure 4.4. Measurement with IS system is following a few 
steps. First, it requires a background recording, and it is performed while all the ports of 
the sphere are blocked, Figure 4.4(a). Then, a reference measurement is performed. The 
reference intensity, Iref, is probing the light flux filling the sphere without any tissue 
sample present, but with merely a highly diffuse reflective barium sulphate plug at the exit 
port, Figure 4.4(b). The barium sulphate plug is a calibration standard with a well known 
diffuse reflectivity, RBS.  
 
 
 
Figure 4.4 The configuration of the integrating sphere measurements. The basic set-up for 
performing (a) the background measurement, (b) the reference measurement by using the 
calibrated barium sulphate plug at the exit port, (c) the transmitted signal measurement 
through the sample, and (d) the reflected signal measurement from the sample.  
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Next, with placing the sample at the entrance port and keeping the exit port blocked, the 
transmission of light through the sample, IT, is measured, see Figure 4.4(c). Finally, the 
sample is repositioned at the exit port, where the diffuse reflected light from the sample, 
IR, can be measured. For this measurement the entrance port is kept open, see Figure 
4.4(d). The reflectance and transmittance can then be determined by the following 
formulas, respectively:  
 
ref
R
BS I
IR  R ⋅=                                                           (4.2) 
 
ref
T
I
I  T =                                                               (4.3) 
 
By measuring both R and T, µs' and µa can be determined. Thus, so far the method is 
representing a two-parameter technique. To determine the g-value and hence separate µs' 
into g and µs, the sphere measurements are combined with a narrow beam measurement 
(one-parameter technique) to measure the collimated transmittance, see Figure 4.1. From 
this additional measurement one can derive µt, (µt = µa + µs), using the Beer-Lambertian 
law91,92, Eq. (4.1). The reference measurement for the narrow beam set-up is made using a 
water-filled cuvette replacing the sample. Figure 4.5, shows the schematics of an 
integrating sphere set-up.  
 
 
 
 
 
Figure 4.5 The schematic set-up of an integrating sphere system. Sample is placed at 
positions indicated by T, R, and Tcol for measurements. Neutral density filters are used to 
attenuate the reference signal in the  collimated beam par (modified from Ref93). 
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There is a slightly modified version of this system, containing two spheres, called double-
integrating sphere system. Two integrating spheres placed so that the exit port of one and 
the entry port of the other are adjacent, with only a sample intervening; will allow the 
simultaneous determination of the reflectance and transmittance of the sample. A sample 
in between the spheres is illuminated with a collimated beam; and the reflectance is 
measured in the first sphere, the diffusely transmitted light is measured in the second 
sphere and the collimated transmission is measured at some distance from the sample 
through a hole in the second sphere94.  
 
While the measurements with double integrating spheres are simplified as compared to the 
single sphere setup, the analysis becomes more complex. This is due to the exchange of 
light between the spheres, an effect that one has to compensate for in the analysis. Thus 
the measured signal is always greater than or equal to that for the single sphere, and the 
increase of the signal depends on both the reflection and transmission properties of the 
sample 89.  
 
Analysis of the optical properties from the three measured parameters, R, T, and µt, can be 
performed by an iterative algorithm, based on forward adding-doubling and/or Monte 
Carlo based methods, discussed in Chapter 3. Both these models have their own 
advantages and disadvantages. Adding-doubling provides quick computations, but it may 
provide imprecise values due to lateral losses of light caused by the finite size of the 
sample and/or integrating sphere ports, which cannot be modelled. These losses lead to an 
underestimation of R and T compared with the ideal case, which in turn lead to 
overestimation of the absorption coefficient of the sample55,95,96.  
 
These lateral losses can easily be incorporated in the Monte Carlo method. Normally 
Monte Carlo simulation-based evaluation requires extensive computation and thus takes a 
relatively long time. To solve this problem and allow a quick extraction of the optical 
properties from the measured R and T, a new method, based on a Monte Carlo database 
and a polynomial regression technique63, employing Newton-Raphson algorithm, is 
presented in Paper I, and also is utilized in Papers II and V.  
 
In order to interpret the results in an adequate way, the sources of errors in measurements 
with integrating sphere system, both for the sphere part and the narrow beam set-up, must 
be taken into consideration. In total, reflectance or diffuse transmittance cannot be 
measured perfectly, due to the losses of light at the different ports of the sphere. Results 
from the reference measurement could be sufficient  to compensate for these losses. A 
problem is, however, that the sample placed at the entrance port (for T measurement), 
reflects some of the light that has entered the sphere. An improved correction can be 
introduced in the analysis expression89,97so that Eq. (4.3) can be rewritten as:  
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where sε is the ratio between the sample port area and the total sphere area, and Rw is the 
reflectance of the sphere wall55. For a double-integrating system this correction factor is 
more important to incorporate the cross talk between the spheres in the analysis. 
 
Another source of errors may be losses of light due to the size of the sample used for 
sphere measurements. The sample must cover the entire port of the sphere, and also a large 
port/beam diameter ratio is necessary to avoid overestimated absorption for samples with 
low absorption95,96. Moreover, Monte Carlo computations incorporating lateral boundary 
conditions reveals that too small samples can decrease the accuracy of the sphere 
measurements15, leading to an overestimation of the absorption coefficient. In fact, 
measurement with an integrating sphere is very critical for samples with very low 
absorption coefficient. This limitation constitutes another major weak point of this system. 
Errors in measurements of R and T directly effect the evaluation of µa, so that for small µa, 
even 1% error in the measurements could lead to relative errors of several hundred percent 
in µa
55.  
 
The sphere part of Figure 4.5, is illustrating  the arrangement of the integrating sphere 
system63,98 used  in Papers II, and V. Guiding light along a 600-µm optical fiber from the 
light source (Xe-lamp), to the sample mounted on the sphere, provides light in a broad 
spectral region. The light was formed into a ~2 mm parallel light beam using a positive 
lens with a 10 mm focal length. This resulted in a beam width of a couple of millimetres. 
This should be compared to the diameter of the entrance and exit ports of the sphere of 2.5 
cm. In addition, the samples were prepared with a size of 2.5 x 2.5 cm, entirely covering 
the entrance and exit ports of the sphere.  
 
As discussed earlier, the purpose of the narrow-beam measurement is to detect the 
unscattered light passing through the sample. Compared to the sphere measurements, 
optically thinner samples are used for the collimated measurements. The reason is to avoid 
as much as possible of the scattered light to be detected. In practice the detected signal is 
measured as the following, 
 
scolmeas III ε+=                                                           (4.5) 
 
where ε  is the fraction of the scattered light that falls inside the collection angle of 
detection, Imeas and Is refer to the measured and the scattered light, respectively
55.  
 
The error increases linearly with sample thickness and scattering coefficient, quadratically 
with the collection angle, and is inversely quadratically proportional to (1-g) and the 
refractive index of the sample75. Another problem in narrow beam measurements is the 
limited dynamic range in the detection. The use of calibrated neutral density filters in the 
reference measurement brings down the signal level in this measurement to that in sample 
measurements, and can thus solve this problem.  
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4.4.2 The combined angular and spatially-resolved head sensor 
 
Integrating sphere measurements are widely used as a reference method for determination 
of the optical properties of turbid samples63,99,100. However, this technique is associated 
with bulky equipment, complicated measuring techniques, interference compensation 
techniques, and inconvenient sample handling. A new technique that resembles the 
integrating sphere method has been presented in Papers I, II, and V. As shown in these 
Papers, the integrating sphere can be replaced by a new compact device, which is called 
the Combined Angular and Spatially-resolved Head (CASH) sensor, to measure the 
optical properties of thin turbid samples in some applications. The CASH sensor is a new 
compact device, which may prove to be a good alternative to the integrating sphere 
system. The device designed and constructed in collaboration between Bang & Olufsen 
Medicom A/S, Denmark and the Department of Physics, Lund University.  
 
This technique is fast and accurate, useful for real-time determination of the absorption 
coefficient, the scattering coefficient, and the anisotropy factor of thin turbid samples. The 
technique is based on a simple continuous wave (i.e., steady-state) non-coherent light 
source. The three optical properties are extracted from recordings of angularly resolved 
transmittance in addition to spatially resolved diffuse reflectance and transmittance. The 
data evaluation is based on a multivariate calibration and prediction technique consisting 
of multiple polynomial regression (MPR)63of Monte Carlo produced data followed by a 
Newton-Raphson101algorithm to extract the optical properties. The evaluation is similar to 
the technique used for the integrating sphere data discussed above. The optical properties 
can be determined from two to four combined recordings of angularly resolved 
transmittance, spatially resolved diffuse transmittance, and spatially resolved diffuse 
reflectance of the sample.  
 
 
 
 
Figure 4.6 Geometric configuration of CASH sensor developed for measuring µa , μs , 
and g . In the figure R and T denotes the spatially resolved diffuse reflectance and 
transmittance, respectively with radial distance r. The angularly resolved transmittance is 
denoted αi , where θ is the deflection angle and φ is the acceptance angle. Finally, ds is 
the sample thickness, db is the diameter of the collimated source beam, and dw is the 
thickness of the cuvette walls. 
ds 
db 
rR rT 
dw 
R T
αi 
θ
φ
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The basic geometric configuration of the setup for the analyses used in Paper I, is shown 
in Figure 4.6. The setup models a cuvette with sample thickness ds = 1.0 mm, wall 
thickness dw = 1.0 mm, and collimated beam diameter db = 1.0 mm. The refractive indices 
of the sample ns, the wall nw, and the surrounding media nm are 1.49, 1.33, and 1.00, 
respectively. Recordings of the spatially resolved diffuse reflectance and transmittance 
from the cuvette are denoted as R and T, respectively, whereas various recordings of the 
angularly resolved transmittance are denoted as iα , where i = 1, 2, . . . The geometry 
shown in Figure 4.6 is one alternative to measure four properties, with which we are able 
to determine the optical properties of the sample. Also other geometrical configurations 
were evaluated in Paper I. Four such possibilities are schematically shown in Figure 4.7.  
 
In Paper I, a series of MC simulations57, based on the geometry specified in Figure 4.6 was 
carried out to investigate the optical property prediction performances of the four 
configurations shown in Figure 4.7. Thus, in each single MC simulation, R and T were 
recorded as a function of the radial distance rT and rR, respectively, and αi was recorded as 
a function of the deflection angle θ and the acceptance angle φ. In each case, rT and rR 
varied within the ranges 0–10 mm in steps of 0.1 mm, whereas θ varied within the range 
0°–90° in steps of 0.25°.  
 
 
 
 
Figure 4.7 Four different setups used to predict optical properties 
using various combinations of spatially or angularly resolved data. 
Each single setup can be used for determination of (a) µa, µs, and 
g; (b) µs and g; (c) µa and µs'; (d) µa, µs, and g. See Figure 4.6 for 
nomenclature. 
 
The scored recordings of R, T, and α were obtained and stored in a calibration matrix, i.e., 
a database containing all combinations of a number of values of µa, µs, and g within the 
typical biological ranges41, 
 
0 < µa < 2 cm-1 
 
10 < µs < 200 cm-1 
 
0.85 < g < 0.99                                                     (4.6) 
α3
α2 
α1 
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The calibration matrix applied throughout this Paper was generated using 106 photon 
packets in each single case. As presented in Paper I, the numerical test results based on 
Monte Carlo simulations show mean prediction errors of approximately 0.5 % for all three 
optical properties within ranges typical for biological media. In addition, to support the 
presented numerical results, preliminary experiments were performed using measurements 
on solid epoxy phantoms102 (see Chapter 3) and milk samples. These experiments were 
carried out using a laboratory setup based on the geometry shown in Figure 4.7(d). In this 
case, the thickness of the samples ds was 1.0 mm; the radial distances rR and rT were 2.5 
and 2.0 mm, respectively; and the angles α1 and α2 were 0° and 5°, respectively. 
Furthermore, a He–Ne laser (633 nm) with a beam diameter db of 1.0 mm was used as a 
light source. Optical fibers were used to collect the output signals from the setup. These 
fibers were connected to a set of silicon detectors with matching amplifier electronics 
mounted in a separate box. This box was connected to a data-acquisition PC board 
controlled by LabVIEW software. These preliminary experimental results presented 
exhibited errors of approximately 5 % as compared with the known optical properties of 
the samples. This demonstrated, in our opinion, a substantial potential of the proposed 
method for simultaneous absorption and scattering characterization of turbid media. 
 
Such instrumentation is especially interesting because of its obvious advantages compared 
with integrating-sphere-based methods, e.g., (a) the sample does not have to be moved 
during the measurements, providing possibilities for true  real-time analysis; (b) no bulky 
spheres are needed; and (c) no technically complicated collimated transmittance 
measurements are required, and (d) it is quite cost-effective. 
 
 
4.4.2.1 CASH sensor measurements on brain tissue  
 
Optical measurements of brain tissue have recently attracted much interest, especially for 
brain activation studies103-107, and for planning photodynamic therapy (PDT) (see Chapter 
7) in the treatment of brain tumors108-111. Another area of interest is the assessment of 
lesion size and site during radio frequency (RF) ablation for the treatment of motor 
disorders caused, for example, by Parkinson's disease112. In Papers II and V, results from 
optical measurements on normal and coagulated porcine brain tissue are presented using 
both the CASH sensor and an IS system as a reference system. 
 
The aims of this work were to measure the optical properties of porcine brain tissue before 
and after coagulating with a monopolar radio frequency electrode and to evaluate whether 
our newly developed instrument could provide accurate results for real tissue 
measurements. In this study we focused on measuring the absorption (µa) and reduced 
scattering (µs') coefficients, as these measurements can be compared with IS 
measurements without using the narrow-beam set-up. We limited the evaluation of the 
optical properties to the spatially resolved diffuse reflectance (R), and angularly resolved 
diffuse transmittance ( 0α ), using the set-up that schematically is shown in Figure 4.8. 
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Figure 4.8 CASH sensor set-up. R, T, 0α  and 5α  denote light referred to as reflectance, 
transmittance, and angular transmittance at 0˚ and 5˚ to the detectors, respectively. The 
light is collected by optical fibers. Neutral density (ND) filters were used to increase the 
dynamic range of the measurements. 
 
As it is shown in Figure 4.8, a 2 mW HeNe laser (633 nm) with a beam diameter of 1.0 
mm was used as a light source. Part of the beam was split off to a reference detector to 
check that the output from the laser remained constant throughout the measurements. The 
rest of the light beam was aligned and sufficiently focused to pass through a φ=1.0 mm 
pinhole in a black metal sheet to irradiate the central part of the cuvette. The cuvette was 
mounted between two black metal sheets. In the centre of the cuvette, transmitted light 
could escape through a φ=1.0 mm hole. Two 400 μm core diameter optical fibers were 
placed at a distance of 75 mm from the cuvette surface to collect light escaping at two 
angles of 0o and 5o, the signals being denoted α0 and α5, respectively. The flat polished 
ends of two other 400 μm fibers were mounted in holes next to the cuvette at radial 
distances of 2.5 mm (R) and 2.0 mm (T). In the measurements performed in Papers II and 
V, only the α0 and R signals were used in the subsequent analysis, as in the project, the 
aim was to extract two coefficients only - μa and μs'. The optical fibers were terminated on 
Si detectors controlled by a LabVIEW© PC card. The detectors were used to read the light 
intensities from each fiber. All signals were recorded simultaneously using an exposure 
time of 10 ms.  
 
To calibrate both the systems, liquid samples with known optical properties containing a 
mixture of intralipid-ink and water were prepared in ten groups. Each group contained ten 
samples with fixed intralipid concentration, providing a constant scattering coefficient, 
while the concentration of ink was varied in between 0.001 % - 0.1 % to provide ten 
different absorption coefficients. Likewise, the intralipid concentration was varied 
between groups within the range 0.4 % - 6.8 % to provide ten different scattering 
coefficients. In this way a matrix of samples was formed with known optical properties, 
covering the typical biological range of absorption and scattering coefficients, 
 
  0. 1 cm-1 ≤ µa < 10 cm-1 
5 cm-1 ≤ µs' < 85 cm-1                                             (4.7) 
Incident laser beam 
(He-Ne, 633 nm) 
Beam splitter 
ND filters 
R 
T 
Lens 5α  
Sample position 
0α
Reference detector 
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Identical cuvettes were made for the measurements, consisting of two glass microscope 
slides (1 mm thickness) glued with an air gap of 0.3 mm between them. One end was left 
open so that the liquid sample could be introduced.  
 
The brain tissue samples were obtained from five Swedish native-bred pigs. Five slices of 
the white matter and five slices of the coagulated samples were prepared with 0.3 mm 
thickness, placed between two glass plates, and investigated with the optical systems. 
Small slices were cut to a thickness of 0.3 mm, 2 cm in diameter. The glass slides were 
marked to ensure that the same part of each sample was irradiated in all the measurements. 
The optical measurements were performed within 3 h after thawing. During this time the 
samples were stored at room temperature wrapped in thin plastic film.  
 
For data processing, a multiple polynomial regression (MPR) technique was used, 
employing fitting of an analytical expression to a discrete number of measured or 
modelled data points63. In this way a simple expression was obtained describing the 
behaviour of the measured parameters as a function of the optical properties. This provides 
a fast and accurate method for applications involving real-time, multi-parameter extraction 
problems. Rapid data processing is of particular importance for spectral recordings 
including data from a large number of wavelengths. The MPR method was utilized to 
calibrate and evaluate measurements from both the IS system and the CASH sensor. The 
calibration process presenting in Papers II and V are slightly different. In Paper II, the 
prepared intralipid-ink samples with known optical properties, were divided to two parts. 
One part were used for calibrating the systems and the other part for evaluation of the 
measured values, Figure 4.9. The evaluated µa and µs' obtained from each system are 
shown in Figure 4.10.  
 
 
 
Figure 4.9 a) Fitted polynomials for R and α0, and b) measured values of R and α0. 
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Figure 4.10 Absorption (µa) and reduced scattering coefficient (µs') of the intralipid-ink 
samples measured with the IS and CASH sensor. a) and b) show µa and µs' measurements 
with IS; c) and d) show µa and µs' measurements with the CASH sensor. 
 
The precision and accuracy of the systems were quantified from these data. The 
inaccuracy was calculated according to Eq. (4.8), while the spread in data, given as the 
coefficient of variation (CV), was calculated using Eq. (4.9). The results are presented in 
Table 4.1. 
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Table 4.1 Estimated inaccuracy and coefficient of 
variation of µs' and µa measurements of intralipid-
ink samples, with the IS and CASH sensor. 
Inaccuracy (%) CV (%) 
Instrument 
µa       µs' µa       µs' 
9          5 16        1 
 
Integrating Sphere 
 
CASH sensor 
 
12         1 17        2 
 
For data processing in Paper V, first the IS system was calibrated using a MC simulations. 
The system was then evaluated with the whole set of intralipid-ink samples. The CASH 
sensor was subsequently trained by half of the samples, while the other half was used for 
evaluation. The code provided by Wang and Jacques56, was used for the Monte Carlo 
simulations. The Rtot and Ttot values were simulated for a 38 x 38 matrix of µa and µs'. 
The values in these matrices were chosen so that their distributions were wider than their 
typical biological ranges41,94. The anisotropy factor (g) and the refractive index (n) were 
kept fixed to n = 1.4 and g = 0.9 in the simulations. 
 
The geometry of the sample in the simulation was a semi-infinite slice of 0.3 mm 
thickness. The samples were placed between two glass slides with a thickness of 1.0 mm 
and n = 1.5. The beam diameter was set to 2 mm and the acceptance hole of the ports to 
the integrating sphere to 25 mm. In each simulation, 1 x 105 photons were traced. Figure 
4.11 shows the simulated functions Rtot (µa, µs') and Ttot (µa, µs') obtained from Monte 
Carlo simulations for the integrated sphere, and the fitted Rtot (µa, µs') and Ttot (µa, µs') 
functions using multiple polynomial regression. 
 
 
Figure 4.11 Reflectance and transmittance as a function of the absorption coefficient, µa, 
and the reduced scattering coefficient, µs', for a thin slice geometry. Rtot and Ttot were 
generated with a) Monte Carlo simulation, b) MPR. 
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Table 4.2, shows the inaccuracy and the coefficient of variation (CV) for the evaluated µa 
and µs' of the intralipid-ink samples. 
 
 
 
 
 
 
 
 
 
 
After completing the evaluation of the systems, measurements on brain tissue samples 
from pigs were performed. Figure 4.12, shows the IS measurement results for these 
samples. Both absorption and scattering exhibit considerable variations in spectral shape 
between the two kinds of samples (normal white matter and coagulated tissue). Also, a 
cross talk between the absorption and scattering is clearly visible in some of the scattering 
spectra in the wavelength regions of the haemoglobin peaks (the scattering spectra are not 
supposed to exhibit any structures in these wavelength regions). The influence of this 
cross talk falls, however, within the limits of measured accuracy of the technique. 
 
As the CASH sensor measures the light scattered from a considerably smaller volume, 
measurements could be performed on smaller, visually more homogeneous, regions of the 
samples, and several measurements could be performed at different positions in the same 
sample. The CASH sensor provided very reproducible results, and results from different 
measurements on the same sample but at slightly different positions gave a CV of 8 % for 
µs' and 15 % for µa in normal white matter; and 4 % for µs' and 17 % for µa in coagulated 
brain tissue. All measurements on a single sample with the CASH sensor were recorded 
from visually similar tissue. The variations in µs' are thus much higher than for the 
variations in homogenous intralipid-ink samples, while the variations in µa already are 
quite high in these samples, and no difference could be observed for the brain samples. 
Results for absorption and scattering at 633 nm are presented in Papers II and V. 
 
In general, the results compare very well with data obtained with an integrating sphere for 
well-defined samples. The instrument is shown to be accurate to within 12 % for µa and 1 
% for µs´ in measurements of intralipid-ink samples. The corresponding variations of data 
were 17 % and 2 %, respectively. The reduced scattering coefficient for porcine white 
matter is measured to be 100 cm-1 at 633 nm, while the value for coagulated brain tissue is 
65 cm-1. The corresponding absorption coefficients are 2 and 3 cm-1, respectively. The 
measured optical properties for the pig brain tissues were compared with the previous 
measurements, performed by Yaroslavsky et al.113, on human brain tissue. 
 
Table 4.2 Estimated inaccuracy and coefficient of 
variation of µs' and µa measurements of intralipid-
ink samples, with the IS and CASH sensor. 
Inaccuracy (%) CV (%) 
Instrument 
µa       µs' µa       µs' 
9          7 10        3 
 
Integrating Sphere 
 
CASH sensor 
 
12         1 17        2 
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Figure 4.12 Evaluated spectra from porcine brain samples from five animals measured 
with the integrating sphere set-up. a) µa and b) µs' measurements of coagulated tissue; c) 
µa and d) µs' measurements of white matter. 
 
 
It must be mentioned that for the measurements of brain tissue, the same intralipid-ink 
training set was used. A small error is then introduced, as the g-factor is expected to be 
different for brain samples. In a previous study, it was shown that a variation of "g" 
between 0.8 and 0.99 resulted in a ±2.5 % error in evaluated reduced scattering 
coefficient63. We thus believe that the effect of an assumed error in the g-factor used in the 
training set in the presented study could be neglected. It is also interesting to note that both 
systems yielded a better accuracy and lower CV for the reduced scattering as compared to 
the absorption coefficient. This is probably due to the small sampling distance of the light 
within the tissue, resulting in a low probability of absorption. It is therefore difficult to 
evaluate the absorption property with high precision. This has been discussed in the 
past102. 
 
The variations observed from the tissue measurements are thus not believed to be due to 
noise in the measurements, but rather due to true variations between the samples. This is 
also suggested by the low observed variations within the same sample. Besides, the 
variation of the results obtained from the IS measurements was higher compare to the 
CASH sensor measurements. These small scale variations within tissue may complicate 
  
81
any diagnostic technique based on optical spectroscopy. A probable explanation of these 
variations is the heterogeneity of brain tissue. In these measurements, it was sometimes 
difficult to measure white matter or coagulated tissue only, as light was collected out to a 
distance of 12 mm from the optical axis in the IS set-up. This was sometimes sufficiently 
large to cover not only the targeted tissue, but also other parts of the samples, meaning the 
areas not intended to be included in the measurement. It is thus important to conduct local 
measurements of optical properties, as brain tissue is very heterogeneous. The CASH 
sensor could be considerably better than the IS in this respect, as the probed volume is 
smaller. For this sensor, only light at a radius of 2.5 mm is detected. Measurements of 
neighbouring areas within the same brain tissue sample with this sensor also produced 
values within 5 % of each other (see Paper V). Interestingly, the optical properties for the 
coagulated brain tissue varied considerably more than those for the normal white matter. 
This might be due to regions of white matter intermixed with gray matter inside the 
coagulated volume. The targeted area for coagulation was always gray matter. Other 
factors that may cause variations in measured results are slight variations in sample 
preparation, sample thickness, sample positioning, etc. 
 
 
4.5 Effects of tissue preparation 
 
The absorption properties in vivo depend on both circulation and the oxygen saturation of 
the tissue. These effects are not presented in in vitro measurements, which means that the 
obtained absorption coefficient do not reflect the in vivo situation. The scattering 
properties are, however, usually relatively unchanged by in vitro handling, with exception 
of fatty tissue if the temperature is allowed to drop to room temperature, which causes 
crystallization of the fatty acids55. 
 
It is known that tissue preparation affects the measured optical properties. Mainly the 
absorption coefficient is believed to alter, due to loss of liquid constituents in tissue. For 
example it is shown that the effective light attenuation of tissue may change by a factor of 
two or more in the visible wavelength range where blood is the main absorber73,114. Also, 
the transmission of light through tissue may be altered by freezing and thawing73. The 
structural changes resulting from freezing and the reduction in tissue water content upon 
thawing, affect the optical response of tissue. A 39 % and 160 % change in transmission of 
thick sample at 488 and 514 nm, respectively; due to prefreezing has previously been 
reported41. This suggests loss of haemoglobin as a result of the freezing, and the effect is 
therefore most probably dependent on exactly how the samples are frozen. Also, it has 
been demonstrated that the optical properties measured from thick samples are generally 
smaller than those measured from thin samples115. These observations suggest that one 
should be aware of these problems especially in evaluation of the absorption coefficient of 
tissue from ex vivo (in vitro) measurements.  
 
 
 
 
 
  
 
                                                                         
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Chapter 5 
 
 
 
 
 
Applications adapted to  
sampling and analytical chemistry  
 
 
 
       "The greater danger for most of us 
is not that our aim is too high                     
and we miss it, but that it is 
                               too low and we reach it." 
 
                                                                                                                           Michelangelo 
 
 
 
 
 
5.1 Introduction 
 
In order to perform sensitive diagnostic measurements by determining concentration or 
presence of specific substances, it is often necessary to employ advanced separation and 
identification techniques. Analytical chemistry provides and introduces many different 
methods for these purposes. With techniques used in analytical chemistry, a sample can be 
analyzed quantitatively and qualitatively, but separation and preparation techniques 
usually must be applied before measuring. Sampling and sample preparation are thus two 
very important factors affecting the results of the analysis. A method for analysis must be 
chosen regarding the required accuracy and sensitivity, as well as the type of the sample. 
In case of medical applications, the methods used for sampling is maybe especially 
important and delicate. Instead of surveying all different methods for sampling and sample 
analysis, which is out of the scope of this thesis, only the techniques utilized to measure 
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drug distribution in connection with Photodynamic Therapy (PDT) are discussed here. 
PDT, which is a non-invasive technique in cancer diagnostic and therapy, has been 
discussed in details in Chapter 7. In this chapter, we are interested in exploring the rate of 
penetration of the photosensitizing agent following topical application. In PDT of skin 
cancer, a photosensitizing agent, 5-aminolevulenic acid (ALA), and/or its esters is 
frequently used in a formulation for topical application. This substance is not excited by 
visible light in itself, and therefore, none of the optical spectroscopic techniques can trace 
its penetration into the skin. An alternative approach would be to tag the photosensitizing 
agent and thus be able to detect it. Radio labeling is one such possible approach, although 
not very appealing as it will involve toxic radioactive substances. Another tagging 
technique would be to rely on the antigen/antibody method. Neither this method was 
judged to be very promising, because of naturally existence of ALA in the body. 
Therefore, it seems the only direct possibility to measure the distribution of ALA in the 
skin, is to extract it from the skin after application, and hence one problem is how to 
perform the sampling. The next problem is to find a sensitive method to analyze the 
concentration of ALA in the collected samples. In this chapter, the studied and the 
suggested methods for drug sampling and analyzing are discussed.  
 
 
5.2 Sampling 
 
The intact skin is an organ among other things protecting the body from chemical 
substances in its local environment. The main barrier in the skin for penetration is the 
stratum corneum (SC), with about 10-20 µm thickness. This is a layer of densely packed 
dead cells. If a substance successfully passes this barrier, it is diffusing into the skin until 
it is reaching the blood vessels. Once inside the blood vessels, the substance will be 
distributed systemically to almost the entire body. The first challenge in the investigation 
presented in Paper IV, was to obtain samples from tissues below the stratum corneum. 
Sampling of the concentration of ALA in the deeper layers of the skin as a function of 
depth and/or time, would in theory allow both the diffusion and penetration through SC to 
be determined. For this purpose, a Microdialysis technique was employed.  
 
The main advantages of utilizing a microdialysis technique are the possibilities of 
collecting as many samples as needed, without depleting the tissue liquid; and the ability 
to accuracy position the probe. By using the microdialysis technique, the chemistry of the 
extracellular space in living tissue is monitored. It provides thus no direct measure of the 
processes inside the cells, but rather what happens outside the cells. It thus provides a local 
“preview” of high sensitivity of what goes on in the tissue- before any chemical events are 
reflected in changes of systemic blood levels.  
 
The basic principle of microdialysis is based on mimicking the function of small blood 
vessel in the tissue. A tubular, semi-permeable dialysis membrane perfused with a 
physiological solution, is inserted into the skin, and diffusion of molecules from the 
dermal extracellular space to the perfusate takes place. The perfusate is collected for 
subsequent analysis116, see Figure 5.1.  
 
The fact is that this technique is based on an exchange of molecules in both directions. The 
difference in concentration through the membrane governs the direction of the gradient. 
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Hence, endogenous and exogenous compounds (such as a drug), are collected 
simultaneously.  
 
The gradient of a particular compound depends not only on the difference in concentration 
between the perfusate and the extracellular fluid, but also on the velocity of flow inside the 
microdialysis probe. The absolute recovery (mol/time unit) of a substance from the tissue 
depends also on the “cut off” of the dialysis membrane, the length of the membrane, and 
the diffusion rate of the compound through the extracellular fluid. The reverse holds true 
for substances entering the tissue from the probe.  
 
The “cut off” of the dialysis membrane is usually defined as the molecular weight in 
Daltons at which 80% of the molecules are prevented from passing through the 
membrane116.  
 
                       
  
 
 
5.3 Analyzing methods 
 
As it was discussed already, in selecting method for analyzing the samples, one need to 
consider the type and volume of the analyzed sample and the accuracy required. The 
analysis method can most often be divided in a separation technique to concentrate the 
sample with regards to the substance of interest, and a detection method.  
 
The two most common detection methods for quantifying ALA in biological fluids are 
spectrophotometric117, which often relies on ion-exchange chromatography separation 
followed by an absorbance detection, and fluorimetric118-122, which involves derivatization 
of ALA with a fluorescent label and subsequent analysis by liquid chromatography with 
fluorescence detection.  
 
The fluorimetric method is more specific and sensitive than the spectrophotometric. 
However, it tends to overestimate low concentrations of ALA as was demonstrated in a 
comparative study between the fluorimetric and colorimetric techniques123. This limitation 
is due to the relative nonselectivity of the colorimetric method.  
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Figure 5.1 The principle 
of microdialysis. 
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Two less frequently employed derivatization methods for ALA have been published, one 
based on liquid chromatography (LC) with electrochemical detection124, and another using 
gas chromatography (GC) and electron capture detection125. Capillary electrophoresis126 
and capillary electrophoresis–mass spectrometric127 methods were also recently developed 
to analyze ALA, but, to our knowledge, they have not been applied in clinical settings128.  
 
In an investigation, two analytical methods, High Performance Liquid Chromatography 
(HPLC) and Liquid Chromatography Mass Spectroscopy (LC/MS), were used for 
analyzing the samples provided by microdialysis from normal skin following topical 
application of Methyl-ALA (M-ALA). The results obtained from each method are 
presented and discussed in Paper IV. In the followings, both these methods are discussed 
and explained in more details. 
 
 
5.3.1 High performance liquid chromatography 
 
The history of the high performance liquid chromatography (HPLC) begins in the 
1970's129. Chromatography is a broad range of physical methods used to separate and/or to 
analyze complex mixtures. In general, it can be said that the components to be separated 
are distributed between two phases: a stationary phase bed (solid) and a mobile phase 
(liquid), which percolates through the stationary bed.  
 
For a long time, many different techniques for chemical separation of samples were 
carried out using relatively simple chromatographic techniques, such as paper 
chromatography, open-column chromatography, and thin-film chromatography.  
 
However, these chromatographic techniques were inadequate for quantification of 
compounds and to resolve similar compounds. Later, in about the middle of 1970's, high 
performance liquid chromatography (HPLC) was developed and quickly improved with 
the development of column packing materials and the additional convenience of on-line 
detectors130,131. Modern HPLC has many applications including separation, identification, 
purification, and quantification of various compounds132. A HPLC system in general 
consists of the following parts: mobile phase reservoir, pumps, columns, detectors, 
injectors, and data system. Figure 5.2 shows the schematics of a HPLC system. 
 
Today, optical detectors are most frequently used in liquid chromatographic systems133. 
These detectors pass a beam of light through the flowing column effluent as it passes 
through a low volume (~ 10 ml) flowcell. The variations in light intensity caused by UV 
absorption, fluorescence emission, or change in refractive index (depending on the type of 
detector used) of the sample components passing through the cell are monitored as 
changes in a voltage. These voltage changes are plotted versus time to provide retention 
time and peak area data.  
 
 
 
 
  
87
 
 
 
Figure 5.2 Schematic of a high performance liquid chromatography system. 
 
 
The most commonly used detector in liquid chromatography (LC) is the ultraviolet 
absorption detector 133. A variable wavelength detector of this type, capable of monitoring 
from 190 to 460-600 nm, is suitable as a detection unit for a majority of samples. Other 
detectors in common use include refractive index (RI), fluorescence (FL), electrochemical 
(EC), and mass-spectrometric (MS). The RI detector is universal but also the least 
sensitive. The EC detector is quite sensitive (up to 10-15 mole) but also quite selective. 
The MS detector is the most powerful, as well as the most complicated and expensive one.  
 
The fluorescence detectors are probably the most sensitive among the existing modern 
HPLC detectors. With such detector, it is possible to detect even a presence of a single 
analyte molecule in the flow cell. Typically, fluorescence sensitivity is 10 -1000 times 
higher than that of the UV detector for strong UV absorbing materials. Fluorescence 
detectors are very specific and thus very selective. This can as mentioned provide a very 
high sensitivity, as the background signal is virtually non-existent and signal-to-
background ratio thus becomes high.  
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If the detection of a HPLC system is based on a fluorescence detector, the technique is 
called HPLC-Fluorimetry. Figure 5.3, shows an arrangement for a typical fluorescence 
detector for LC. 
 
 
5.3.2 Liquid chromatography mass-spectroscopy 
 
In the last decade, there is a significant progress in the development of LC/MS interfacing 
systems. MS as an on-line HPLC detector is believed to be the most sensitive, selective 
and in the same time the most universal detector128.  
 
Mass spectrometry is an analytical method used for measuring the molecular weight 
(MW) of a sample, and enables the rapid and easy determination of an accurate molecular 
weight for any given sample. In general, mass spectrometers use the difference in mass-to-
charge ratio (m/e) of ionized atoms or molecules to separate them from each other. Mass 
spectrometry is therefore useful for quantification of atoms or molecules, and for 
determining chemical and structural information of molecules. Various MS approaches 
may be used to analyze the components of samples, and this technique is not restricted to 
particular types of molecules. Each mass spectrometer has three fundamental parts: the 
ionization source, the analyzer, and the detector, as shown in Figure 5.4. 
 
 
 
Figure 5.4 The fundamental parts of a mass spectrometer. 
 
The first step in mass spectroscopy is to introduce the sample under investigation into the 
ionization source of the instrument. The method selected to feed the sample into the 
ionization source often depends on the ionization method being used, as well as the type 
and complexity of the sample. The sample can be fed directly into the ionization source, or 
can undergo some type of preparation, like chromatography, on the way to the ionization 
source. This latter method of sample introduction usually involves the mass spectrometer 
being coupled directly to a high performance liquid chromatography (HPLC), gas 
chromatography (GC) or capillary electrophoresis (CE) separation column, and hence the 
sample is separated into a series of components, which then enter the mass spectrometer 
consecutively for individual analysis134,135. The process of mass spectroscopy is 
schematically introduced in Figure 5.5. 
Detector 
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Ionization 
Source 
X-ray 
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Figure 5.5 Schematics of MS process. 
 
 
Different techniques are used for sample ionization. One of the ionization method used for 
the majority of biochemical analyses is the Matrix Assisted Laser Desorption Ionization 
(MALDI). In the investigation performed in Paper IV, a MALDI time of flight (TOF) 
mass spectroscopy was employed. 
 
To understand how MALDI works; one can follow the below procedures: 
 
1- Sample (A) is mixed with excess matrix (M) and dried on a MALDI plate. 
 
2- Laser flash produces matrix neutrals (M) matrix ions (MH) +, (M-H)-, and sample 
neutrals (A). 
 
3- Sample molecules are ionized by proton transfer from matrix ions: 
 
MH + + AÆM + AH+ 
 
4- High voltage is applied to the sample plate accelerating ions out of the ion source. 
 
With the increase in interdisciplinary research in recent years, the need for accurate and 
sensitive methods for the analysis of biomolecules has been increasingly important for 
both chemists and biologists. Mass spectrometry has been emerged as an important tool 
for analyzing and characterizing large biomolecules of varying complexity. The MALDI 
technique130, developed in 1987, has increased the upper mass limit for mass spectrometric 
analyses of biomolecules to over 300,000 D, and has enabled the analyses of large 
biomolecules by mass spectrometry to become easier and more sensitive. An attractive 
feature of the time-of-flight (TOF) mass spectrometer is its simple instrumental design 
(see Figure 5.6). TOF mass spectrometers operate on the principle that when a temporally 
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and specially well defined group of ions of differing mass/charge (m/ze) ratios are 
subjected to the same applied electric field, they will traverse a certain distance in a time, 
which depends upon their m/ze ratios (K.E. = [mv2]/2 = zeEs, where K.E. is the kinetic 
energy; m is the mass of the ion; v is the velocity of the ion; z is the number of charges of 
the ion; e is the unit charge of an electron; E is the electric field; and s is the length of the 
ion source region). 
 
 
 
Figure 5.6 Schematics of TOF mass analyzer. a) Ions are accelerated with the same 
potential at a fixed point and fixed initial time; b) the lighter ions travel faster and strike 
the detector, before the heavier ions. 
 
 
5.4 Practical applications of Microdialysis, HPLC, and LC-MS 
 
The intention of our research employing the sophisticated analytical chemistry techniques 
described above, was thus to measure ALA penetration in skin. In a first attempt in the 
direction of measuring ALA concentration in biological samples, the idea was to convert 
ALA into a fluorescent molecule that could be more easily detected. The applied method 
is characterized by the formation of a fluorescent ALA derivative and its subsequent 
separation by HPLC. For this purpose, a type of Hantzsch reaction was employed. This 
reaction was first introduced by Okayama et al.136. Fluorescence derivatization of ALA in 
this work was slightly based on modified Hantzsch reaction scheme, in which amine 
compounds react with acetylacetone and formaldehyde137. ALA was in this way 
derivatizated to a fluorescent molecule. The prepared sample was then purified by HPLC. 
The fluorescence intensity of the eluate was monitored at a wavelength of 370/460 nm 
(excitation/emission) with a fluorescence monitor. An advantage of this method is the 
possibility to determine ALA in a small volume of biological materials. The detection 
limit of ALA in fortified sample was approximately 60 ng/ml (≈353 nmole/lit), which was 
not considered sufficient for our application. 
 
M-ALA, which is one of the ALA esters, has an application in dermatology for treatment 
of skin malignancies by PDT. This molecule exhibits better penetration into the skin as 
compared to ALA, because of its lipophilic nature. It is of interest to study how quickly 
M-ALA penetrates the skin, as well as the concentration of M-ALA as a function of depth 
in the skin and time, following topical application (see Paper IV). PDT using ALA and its 
esters are discussed with more details in Chapter 7. 
 
Ion source Ion source Flight tube Flight tube 
 Detector  Detector 
(a) (b) 
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In another attempt, a fluorescence tag was used to label the M–ALA molecules. In this 
study, M-ALA cream (METVIX® 20 %, Photo Cure, Oslo, Norway) was applied topically 
on normal skin. Extracellular fluid samples were obtained from a depth of 500 µm of the 
forearm skin by a microdialysis system with a 100 KD cut-off membrane. As M-ALA is 
not a fluorescent molecule, it needed to be specifically labeled with a fluorescent 
molecule138 in order to be detected by the HPLC-fluorimetric. For this purpose, M-ALA 
was coupled to a strong fluorescent molecule (Edman-type fluorogenic reagents). The dye 
4-(2´-cyanoisoindonyl) phenylisothiocyanate (CIPIC) used as fluorescent molecule. This 
was synthesized as has been described by Imakyure139. M-ALA in the sample was linked 
with CIPIC, and separated by HPLC. A fluorimetric monitor was used at the wavelength 
260/410 nm (excitation/emission). The detection limit for M-ALA in buffer was shown to 
be approximately 100 ng/ml. 
 
It was, however, predicted that the concentration of M-ALA in the biological samples 
obtained by microdialysis was in the range of pg/ml. Therefore, looking for more sensitive 
technique for analysis, an MS detector was suggested. We thus investigated whether it was 
possible to analyze M-ALA in the sample without any derivatization by employing the 
LC/ MS technique. Liquid chromatography was performed on an Agilent 1100 Series, 
using a 4-μm, 150×2 mm Synergi Polar RP (80 Å) column from Phenomenex. The 
sensitivity for detection of M-ALA employing MALDI-TOF MS was assessed using a 
preparation of pure M-ALA in buffer. All MALDI-TOF experiments were performed on a 
4700 Proteomics Analyzer (Applied Biosystems, USA). Di-hydroxy benzoic acid (DHB) 
was used as the MALDI matrix. The signal at 147 D, corresponding to M-ALA, 
overlapped with a signal from DHB and could thus not be used by itself for detection of 
M-ALA. Instead, the signal at 147 D was selected for fragmentation analysis with the 
instrument operated in MS/MS-mode. In the M-ALA samples, a characteristic fragment 
ion signal at 114 D could be detected and was used for identification of M-ALA. Samples 
were directly injected to LC without any derivatization. Fractions were collected around 
the retention time, where M-ALA had shown to be eluted; and then these fractions were 
subjected to the MALDI-TOF/MS system. However, M-ALA could not be detected from 
these samples, likely due to co-elution of some unknown substances, interfering with the 
MALDI sample preparation.  
 
In order to refine the preparation of the samples to obtain more purified samples, 
microdialysis using a 20 KD cut-off membrane, instead of 100 KD, was utilized. M-ALA 
cream was applied on normal forearm skin of three volunteers, and samples were collected 
using Microdialyse every hour and kept in -70 ◦C until analysis. After separation and 
purification by HPLC, collected samples in the desired retention time window were 
vacuumed. For measurement by MALDI-MS, the samples were resuspended in 10 μl 
water. Then, 0.5 μl of each sample was prepared with 0.5 μl of a matrix solution (DHB).  
 
Samples were analyzed in MSMS-mode, but in none of the samples the fragment ion 
signal at 114 D, which has been shown to be indicative of M-ALA, could be detected. It 
seems that the concentration of M-ALA in the sample is still too low for detecting by this 
method. 
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In order to further improve the possibilities to detect the diffusion and concentration of 
ALA derivatives in tissue in connection with PDT, and also to improve the understanding 
of the optimal timing and application route, a few methods are suggested:  
 
1- Studying the concentration of ALA derivatives in lesions with a reduced barrier of SC. 
This is more similar to the situation in malignant skin lesions and will yield much higher 
ALA derivative concentrations in the tissue. 2- Applying other ALA esters, which could 
be more hydrophobic, that could penetrate through SC of intact normal skin more 
efficiently. 3- Utilizing an electrophoresis technique, which can increase the penetration of 
the drug through SC into the skin. 4- Applying tape striping method to overcome the 
barrier effect of SC, and hence providing the facility of the drug penetration into the skin. 
5- Prevention of M-ALA uptake by capillary vessel in dermal area.  
 
 
  
 
 
 
Chapter 6 
 
 
 
 
 
Optical diagnostic techniques  
 
 
 
     "If you want happiness for a lifetime, 
 help someone else." 
 
                                                                                                    Chinese proverb 
 
 
 
 
 
6.1 Introduction 
 
Extensive research has been carried out providing non-invasive techniques for tissue 
diagnostics including delineation and identification of diseased lesions. By help of 
magnetic resonance imaging and X-ray, it is possible to visualize structures inside the 
body. A major weak-point of these techniques is, however, that those investigations are 
normally only offered once a tumor is large enough to cause clinical symtoms140, and at 
this relatively late stage the tumor may be difficult to be treated successfully. The main 
ambition in developing any novel diagnostic technology is to obtain early stage diagnostic 
capability. All physical disorders are associated with physiological, biochemical and/or 
morphological changes of tissues. All these alternations can affect the interaction 
processes between light and tissue from molecular to cellular level15. A very frequent term 
used in optical spectroscopy is "optical biopsy". This means using modifications of the 
optical signals from light-tissue interaction as spectral fingerprints for tissue 
characterization. The idea is not to replace normal biopsies, but rather to guide the biopsy 
collection to the most diseased regions and thereby avoid many unnecessary biopsies. The 
spectral distribution in all optical diagnostic techniques, depend on the illumination and 
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collection light geometry. Depending on the type of light interaction with tissue, four main 
categories of diagnostic techniques are identified: 1- Laser-induced fluorescence (LIF), 2- 
Raman spectroscopy, 3- Laser-Doppler flowmetry, and 4- Elastic scattering spectroscopy. 
In all of these techniques, the outcome results depend on the detection geometry. Different 
angular distributions of the remitted light will, for instance, represent different optical 
paths inside the tissue and will thus provide different signals. The difference depends on 
the optical properties of the tissue. Hence, the optical properties of the tissue can be used 
as a diagnostic parameter. Otherwise, one may want to achieve a detection geometry 
where all remitted light is collected, which can be done by utilizing an integrating sphere, 
explained previously. The problem is that this technique is not clinically practical. Instead, 
a geometry based on optical fibers is suggested. For this reason, in the following, some 
fluorescence techniques are discussed. You will also find a brief description of optical 
coherence tomography for tissue diagnostics. This is an imaging modality based on 
scattered light. 
 
 
6.2 Laser- induced fluorescence 
 
Laser-induced fluorescence (LIF) is a real-time spectroscopic technique that can be used 
to characterize biomedical and morphological changes of different kinds of tissue both in 
vitro, and non-invasively in vivo141. In vitro fluorescence measurements are usually 
recorded from an area of the tissue surface that is large compared with the size of the 
excitation beam. Most clinical applications of fluorescence spectroscopy require that 
spectra be recorded remotely via optical fibers. The fluorescence is therefore collected 
from a relatively smaller area of the tissue surface142,143. The sampling depth for 
measurements of fluorescence is determined by the penetration depth of the excitation 
light, the various fluorescence coefficient of the tissue layers, and the escape functions for 
the fluorescence as well as the detection geometry143.  
 
The fluorophores/chromophores observed in fluorescence spectroscopy of tissue can be 
divided into two main categories: exogenous and endogenous fluorophores. The 
endogenous fluorophores include chromophores that naturally exist in tissue, while the 
exogenous flourophores are obtained by adding tumor marking agents or their precursors, 
providing a contrast between tumor and normal tissues that can be explored for diagnostic 
purposes. Examples of the latter type of fluorophores are the ones applied as 
photosensitizers in photodynamic therapy (PDT), (see Chapter 7). Laser-induced 
fluorescence can in this respect be a very important tool in PDT for monitoring the level of 
photosensitizers, and optimizing the treatment. 
  
It is often the shape of the fluorescence spectra that is used for diagnostic purposes, rather 
than the fluorescence intensity. Changes of the excitation and/or emission spectral 
between the normal and malignant tissues can thus provide an important tool for tissue 
diagnostics. This makes the measurement slightly less dependent on the detection 
geometry and the exact excitation power and detector sensitivity.  
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6.2.1 Autofluorescence 
 
Fluorescence that is obtained from endogenous tissue fluorophores, without adding any 
external fluorophore, is called autofluorescence144. Alterations in tissue composition 
between normal to malignant tissue forms a basis for the diagnostic potential for 
demarcating neoplastic tissue145. Tissue fluorophores will normally fluoresce in the visible 
wavelength range following excitation with radiation in the UV and near-UV region. The 
auotofluorescence intensity is frequently reduced from tumor tissue as compared to the 
surrounding normal tissue146-148. The endogenous tissue fluoropores can be divided into 
two main groups, one group involve in the cellular energy metabolism, and the other one 
in the structural proteins149. The most important tissue fluorophores are collagen, elastin, 
NADH/NADPH150,151. It should be mentioned that all fluorescence spectra recorded from 
tissue is also influenced by the tissue optical properties, meaning those absorbers, which 
do not fluoresce, but absorb either the excitation or fluorescent light. These absorbers will 
affect the overall intensity of the fluorescence spectra, while the shape of the spectra will 
usually be affected to a lower extent as the absorption coefficient in the visible region is 
lower than for the excitation light in the violet or near-UV region151,152.  
 
 
6.2.1.1 Collagen and elastin 
 
Collagen and elastin are proteins associated with the structural matrix of tissue. There are 
several different types of collagen with slightly different absorption and fluorescence 
emission characteristics33. They are found in connective tissues, and dominate the 
autofluorescence when the excitation wavelength is about 337 nm. 
 
 
6.2.1.2 NADH/NADPH and flavins 
 
Nicotinamid adenine dinucleotide (NADH) is involved in the cell metabolism. NADH is 
mostly situated in the mitochondria. NADH has its excitation peak at 350 nm and emits at 
460 nm. NAD+ is the oxidized form of the NADH, and does not fluoresce if tissue is 
excited above 300 nm. As malignant tissues are associated with and increased metabolism, 
and intense oxygen consumption, the lower level of oxygen and hence reduction of pH-
value, affect the alternation level of NADH/NAD+ and their concentration, and the 
outcome of the tissue autofluorescence. Therefore, NADH is playing very important role 
in detecting the early-stage malignancies13,153. 
 
 
6.2.1.3 Other fluorophores 
 
Tryptofan is a fluorephore involved in the cellular metabolic pathway. It is an amino acid 
with maximum excitation/emission rate at 275 nm and 350 nm, respectively. This 
fluorephore is useful as an indicator for cell metabolism154. Other important tissue 
fluorophores are known as, flavins and flavoproteins, beta-carotene, and porphyrins, 
which are reviewed in references9,151,155, see also in table 1. 
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Table6.1 Some of the most important fluorophores in tissue. 
 
Endogenous fluorophor λexc (nm) λem (nm) Type 
Tryptophan 
Collagen 
Beta-caroten 
Elastin 
Keratin 
Porphyrin 
Flavins 
275 
325,333, 370 
 
420,460,360,425 
370 
400 
450 
350 
380,400,460 
520 
500,540,410,490 
460 
610, 675 
512,525 
Metabolic 
Structural 
 
Structural 
Structural 
Metabolic 
Metabolic 
 
 
6.2.2 Fluorescent tumor markers 
 
In order to increase the potential of diagnostics by fluorescence, exogenous fluorescent 
tumor markers are sometimes utilized. The externally applied fluorescent substances are 
tumor selective, and can be administrated topically, orally, or intravenously. These 
markers are often selected to have fluorescence emission in the red and near infrared 
wavelength region and can thereby be distinguished from the blue-green autofluorescence 
emission. Hematoporphyrin derivatives are well-known tumor markers and as discussed 
above, these substances are also utilized as photosensitizer for PDT.  
 
Protoporphyrin IX (PpIX) that naturally exists in the body is another substance used both 
as a fluorescent tumor marker and a photosensitizer for PDT. PpIX is one of the 
intermediate products in haem-cycle. An elevated PpIX concentration can be obtained 
through the haem-cycle following administration of 5-aminolevulinic acid (ALA). This is 
widely utilized for PDT. PpIX has also been identified as a fluorescent tumor marker for 
specific tumor types. The tumor localizing characteristics of ALA-induced PpIX is well 
documented156-158. Excited at 405 nm light, PpIX exhibits a dual-peaked fluorescence 
emission in the red region, one at approximately 635 nm and the other at about 705 nm. 
Many investigations have been performed to examine the kinetics of the PpIX build-up 
following administration of ALA and its derivatives by use of LIF159,160. Much lower 
doses of PpIX (or ALA) are necessary for diagnostic as compared to therapeutic 
procedures.  
 
Figure 6.1, shows fluorescence emission spectra from some of the mentioned tissue 
fluorophores following excited with 337 nm light, and a comparison between the 
fluorescence spectra obtained from a premalignant lesion and the normal surrounding 
tissue in vivo after administration of ALA. The wavelength of the excitation light was 405 
nm, the dual emission peak from PpIX are obtained at and 635 nm and 705 nm. 
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Figure 6.1 Fluorescence spectra; (a) from some important tissue fluorophores following 
337 nm excitation, (b) typical average fluorescence spectra obtained in vivo from normal 
and premalignant lesion on vocal folds, using 405 nm excitation light where ALA has been 
applied prior to the examination. Modified from Ref161 
 
 
6.3 Fluorescence monitoring 
 
In general, LIF method can be divided into point monitoring techniques and imaging 
methods. The main advantage of using point-monitoring method is the possibility of 
interstitially application of fluorescence, as in this method optical fibers are used. In this 
method, the excitation light is guided through an optical fiber probe, and the tissue 
fluorescence is detected through the same or another fiber. The intensity of the excitation 
light and the geometry of the sample and fibers will influence the results of the 
measurements. 
 
On the other hand, the presence of absorbing molecules such as haemoglobin and melanin, 
which do not fluoresce, is also an important factor that must be taken under consideration 
in fluorescence diagnostics. The observed fluorescence from biological tissue is often a 
composite signal and significantly distorted by absorbers and scatterers as compared to 
fluorescence spectra from pure chromophores. Recorded spectra cannot therefore be 
interpreted as the intrinsic fluorescence without interference of absorbers and scatterers 
present in the tissue analyzed162.  
 
The outcome of the measurement on the same sample alters when a point illumination is 
used compare to broad illumination geometry. Also, the exact measurement geometry 
influences the recorded fluorescence emission spectrum. These aspects are demonstrated 
in the Figure 6.2. 
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Figure 6.2 Illustration of the influence of the measurement set-up to the detected 
fluorescence signal. Modified from Ref163. 
 
 
Another important factor in point monitoring fluorescence spectroscopy is the choice of 
optical fiber(s). Optimization of quantitative fluorescence spectroscopy devices for 
medical diagnostics involves specification of a variety of system components including 
light sources, spectrometers, detectors, and accessories for light delivery and collection. 
Fiber-optic probes are often used to provide the interface between source and tissue as 
well as between tissue and detector164. Investigations indicate that fiber-optic probe design 
parameters have strong influence on the relative sensitivity to fluorophore layers in turbid 
media165.  
 
In Figure 6.3, two types of fiber-optic probe geometry are compared. Moreover, 
computational modeling results indicate that the fiber-optic probe design strongly affects 
light propagation and fluorophore detection. It is known that source and collection fiber 
size influences the detected fluorescence intensity. Increasing the source and/or detection 
diameter causes an increase in the attenuation164. Regarding the fiber-optic design, other 
parameters such as illumination-collection fiber separation, and fiber-tissue spacer size, 
affect the outcome of the measurements, as well as use of single versus multifiber 
probes164,166. In addition, it should be mentioned that longer path lengths and deeper light 
penetration tend to produce fluorescence spectra which are more strongly altered by 
hemoglobin absorption166,167.  
 
The affects of illumination-collection fibers separation, together with the changes of the 
source power have been investigated in Paper III, where the tissue temperature was 
monitored by fluorescence of a specially designed fiber probe including a crystal with 
temperature-dependent fluorescence at the tip. In addition, in this study, the role of 
scattering coefficient variation on fluorescence intensity was investigated in tissue 
phantoms. 
 
Tissue 
500 500 600 600 
(b) (c) 
Fiber 
Tissue 
Detection 
Tissue 
500 600 
(a) 
Fiber 
Detection Detection Excitation Excitation Excitation 
Fiber 
  
99
 
 
 
Figure 6.3 Illustration of fiber-optic probe design parameters and fluorescence light 
propagation in a two-layer phantom for (a) single probe geometry, and (b) multiple-fiber  
geometry. The superficial layer and the deeper layer contain Fluorescein and Rhodamine, 
respectively. S is the probe-sample spacing distance, D is the fiber diameter, and L is the 
illumination-detection fiber separation distance. Modified from Ref165. 
 
 
6.3.1 Point monitoring systems 
 
Point monitoring measurements are frequently based on a so-called multi-channel analyzer 
(OMA) system, where a spectrometer and an array detector allow parallel detection of all 
emission wavelengths. Such systems are often based on the use of optical fibers for 
guiding the excitation light to the tissue, and the emitted light from the tissue. A complete 
system is in this way assembled by a spectrometer, a multi-channel detector, a computer, 
and some optical coupling. These parts will all together make an OMA system. The 
limitation of this system is that only small area of tissue is probed, and it may thus be 
difficult to identify the region of interest for such a measurement. For larger area 
investigations, usually imaging systems are preferred. Another aspect is that the 
fluorescence light is usually very weak compared to the excitation light. It is therefore 
necessary to employ a sensitive detector and suppress the background light efficiently. It is 
important to know that the detected fluorescence spectra are affected not only by the tissue 
optical properties, but also by the geometry of the measurement (see Figure 6.2).  
 
Using the illumination/detection fibers, and evaluating the spectrum, one should consider 
that the collected light is dependent on the optical properties of tissue and hence is 
wavelength dependent, and thus, is dependent on the distance between the illumination 
and detection fibers, as well as the distance between the tissue surface and the detector 
fibers. However, it has been shown that in the case of a specific separation of 
illumination/detection fibers, it is possible to have light detection independent of the 
scattering properties15,168. The influence of the illumination/detection fiber distance on the 
intensity of the detected fluorescence is a part of the investigation performed in Paper III. 
 
The choice of light source for excitation is another important factor, which must be 
considered. Using a continuous light source (CW), measurements must be performed in a 
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dark environment to decrease the effect of any background light present. This is due the 
low momentary intensity of the illumination light. Instead, by using a pulsed light source 
with a much higher momentary intensity, together with a gated detector open just during 
the pulse, one can obtain a sufficient fluorescence signal without being sensitive to the 
background light169.  
 
 
6.3.2 Imaging systems  
 
An imaging system is often preferable to use for investigation on larger areas of clinical 
relevance, thus avoiding the random sampling. A multicolor fluorescence imaging system, 
which is used together with endoscope optical fibers, has been developed in Lund. This 
system uses beam-splitting optics to divide the fluorescence light into four images, which 
are spatially identical but filtered in separate wavelength bands. The images are detected 
by an intensified CCD camera. The camera is operated in gated mode to suppress the 
background light. Computer processing of the images yields a fluorescence image with 
optimized contrast between normal and diseased tissue. Choosing suitable detection 
wavelengths and evaluation criteria is important for optimization of the performance of the 
imaging system.  
 
Another imaging approach is fluorescence lifetime imaging. The fluorescent lifetime of an 
endogenous fluorophore may be sensitive to local environments, providing specificity for 
contrast of diseased over normal tissues and optimal detection of disease170. By utilizing a 
gateable image-intensified CCD camera with different delays of the gate with respect to 
the excitation pulse, it is possible to obtain  the lifetime distribution171. 
 
 
6.4 Optical coherence tomography 
 
As has been discussed, optical spectroscopy provides essential ways to characterize 
physical and chemical properties in living tissues and cells and to monitor their functional 
changes occurring. Thus, optical spectroscopy offers exciting possibilities for developing 
computed tomography in the optical region, especially in the red and near infrared regions. 
One can thereby acquire 3D distributions of functional/physiological information. 
Nevertheless, its development and application in living tissues are complicated by the 
strong multiple scattering of light172.  
 
There have been three basic approaches to optical tomography since the early 1980’s: 
optical diffraction tomography (ODT), diffuse optical tomography (DOT), and optical 
coherence tomography (OCT). Specific advantages of OCT are its high depth resolution, 
high probing depth in scattering media, contact-free and non-invasive operation, and the 
possibility to create various function dependent image contrast methods17.  
 
Penetration depth of OCT is determined by the tissue probed, as well as on the emission 
wavelength and source power used. There are two coherence properties playing important 
roles in this technique; the temporal coherence determines the depth resolution, and spatial 
coherence plays a role in both the lateral and depth resolution17.  
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In OCT, light from a source is split into two paths: the sample and reference paths, as in a 
Michelson interferometer. The light in the sample path interacts with the tissue under 
investigation, with some light reflected or scattered back from different structure within it. 
The light in the reference path is reflected back by a mirror to recombine with light 
returning from the sample path. The beams interfere when the difference between the two 
paths is within the coherence length of the light source, and the reference path-length is 
varied to investigate this interference signal for different depths within the sample. The 
use of a broadband source (hence with short coherence length), enables more precise 
location of the depth of a structure within the sample than other techniques173, since 
interference only occurs when the difference between the lengths of the sample and 
reference paths is within the coherence length of the light source. 
 
In an investigation, measurements on several human brain tissue samples have been 
performed using both an OCT system and an integrating sphere system. The concepts and 
preliminary results obtained with both systems are compared and presented in a Paper, 
which is not included in this book. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
  
 
 
 
Chapter 7 
 
 
 
 
 
Photodynamic therapy  
 
 
 
      “Someone is sitting in the shade today 
                                                              because someone planted a tree a long 
                                                                                                           time ago”. 
 
                                                                                                        Warren Buffet 
 
 
 
 
 
7.1 Introduction 
 
One of the most interesting methods in photo treatment, known as Photodynamic Therapy 
(PDT), is discussed in this chapter. PDT is mainly a method to treat superficial and thin 
tumors, by using a combination of a photosensitizing drug and light to cause selective 
damage to the target tissue. An adequate concentration of molecular oxygen is also needed 
for tissue damage. If any one of these components is absent, there is no effect. Moreover, 
the overall effectiveness requires careful planning of both drug and light dosimetry.  
 
 
7.2 History 
 
From history, it is seen that light has been employed in the treatment of diseases since a 
very long time ago174. Photosensitizing drugs have been known and applied in medicine 
for several thousand years. However, the scientific basis for such use, and the concept of 
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cell death being induced by the interaction of light and chemicals175, was vague or non-
existent before about 1900. The term "photodynamic action", was introduced in 1904 by 
one of the pioneers of photobiology, Herman von Tappeiner in Munich, Germany, and 
though it is not clear why he called the process "dynamic", this term is used only for 
photosensitized reactions requiring oxygen. 
 
 
7.2.1 Phototherapy 
 
Phototherapy, also called "Light therapy", in definition means the use of light for 
therapeutic purposes. In phototherapy, the treatment only consists of utilizing light within 
various wavelength bands and intensities. However, in phototherapy, different 
mechanisms and photodynamic processes are involved.  
 
Phototherapy, was known by the Egyptians, the Indians and the Chinese, and has been 
applied since 3000 years ago. The founder of modern phototherapy is Niels Finsen, who 
got the Nobel Prize (1903), for his work on the use of light from a carbon arc lamp in the 
treatment of skin tuberculosis176. The most widely use of phototherapy is in 
dermatology177, for certain types of dermatitis and for psoriasis24. In addition, an expanded 
field of phototherapy, is within psychiatry, where light is used as a therapeutic modality 
for treating depression, sleep disturbances and seasonal affective disorders (SAD)24,178. 
 
 
7.2.2 Photochemotherapy 
 
In one of India's sacred book (1400 BC), it has been written that seeds of the plant 
Psoralea corylifolia can be used for the treatment of vitiligo (an acquired skin disease 
characterized by patches of unpigmented skin, which often is surrounded by a heavily 
pigmented border). Psoralens were also known and utilized by Egyptian for treating 
vitiligo. Psoralens are the photoactive components of these seeds. The chemically 
enhanced phototherapy, which consists of the administration of a photoactive agent and 
subsequent irradiation, is called photochemotherapy (PCT). Photochemotherapy in 
modern age was first reported in 1974, when treatment of psoriasis was performed by 
using a combination of psoralens and UVA (320-380 nm) radiation. This method, called 
PUVA therapy, is still used in dermatology, mainly for psoriasis treatment.  
 
 
7.2.3 Photodynamic therapy 
 
The type of photochemotherapy, which is dependent on the presence of oxygen, is called 
photodynamic therapy (PDT). The first systematic study of photodynamic action was 
carried out in Munich in 1897 by a medical student, Oscar Raab under supervision of 
Hermann von Tappeiner. Tappeiner together with his colleague Jodlbauer, performed a 
large amount of scientific work on photosensitization, and discovered that oxygen was 
required for the photodynamic action (1904). For the first time, he used the term of 
"photodynamic therapy" for this oxygen dependent photodynamic action, and together 
with a dermatologist (Jesoniek), he was the first who performed PDT on humans for 
treating skin cancer. They used eosin as a photosensitizer.  
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Hematoporphyrin and its derivative have been central to the development of PDT. 
Hausmann was the first to study the biological properties of hematoporphyrin, in 1908. In 
1908-1913, a number of photobiological experiments were carried out with 
hematoporphyrin, demonstrating how it is sensitized by light; while the first studies on 
sensitization in humans were performed by Meyer-Betz in 1913, who injected himself 
with hematoporphyrin and remained photosensitized to light for two months. He was 
sensitized similarly to what is seen today during ALA-PDT. More investigations were 
performed by Meyer and Fischer on the importance of porphyrin structure for the efficacy 
of PDT. Fischer's studies on patients suffering from porphyrias, proved the 
photosensitization of skin due to the accumulation of various porphyrins and their 
precursors such as δ-aminolevulinic acid and porphyrinogens, in the skin.  
 
The tumor selectivity of porphyrins was observed by Policard in 1924. It was also 
demonstrated that hematoporphyrin had tumor-localization ability in human malignancies, 
but later on it was realized that hematoporphyrin was difficult to purify and then the search 
for pure substances started. In 1948, Figge introduced hematoporphyrin derivative (HPD) 
as an important substance for cancer detection. 
 
Many clinical and experimental studies regarding the porphyria diseases have been 
performed over many decades. A characteristic symptom of several of these diseases is 
skin photosensitivity. This hypersensitivity is related to the accumulation of 
photosensitizing intermediates produced in the haem synthesis, caused by enzyme 
disorders. The photosensitizer agent most active in pophyria is protoporphyrin IX (PpIX). 
The next major step within clinical PDT, was the introduction of δ-aminolevulenic acid 
(ALA) in the treatment of skin malignancies. Most photosensitizers are large with 
relatively complex molecular structure. An exception to this is ALA, which is precursor of 
the photosensitizing compound, PpIX.  
 
The idea of using ALA for PDT was first reported by Malik et al. and Moan et al. First, 
Malik et al. studied the phototoxic effects of ALA for the killing of erythroleukemic cells 
in vitro. Then ALA-mediated PpIX production in normal skin of mice was reported. 
Furthurmore, Kennedy and Pottier successfully treated human skin tumors with topically 
ALA-based PDT179. Since then, ALA-PDT has been used in a large number of clinical 
specialties. 
 
The history of PCT and PDT has been presented in review papers, where references to the 
above mentioned work can be found174,177,180,181. 
 
 
7.3 Principles and mechanisms of photodynamic therapy 
 
The treatment of tumors with PDT includes three major parameters: administration of a 
photosensitizer that is selectively accumulated in the tumor, subsequent exposure of light, 
and presence of oxygen in the tumor tissue.  
 
When the photosensitizer molecule absorbs a photon of light with specific wavelength, the 
molecule will be excited from its stable ground state to its first excited singlet state (S1). 
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This absorption band is called the Q-band. The molecule in this state has a short lifetime. 
From here, the molecule has two possibilities to return to the ground state, either the 
molecule returns to the ground state by emitting a photon (fluorescence), or by internal 
conversion with excess energy lost as heat; or the molecule may take the inter-system 
crossing, and be transferred to the lowest triplet state (T1) and then to the ground state 
(S0); see Figure 2.3.  
 
The triplet state photosensitizer has lower energy than the singlet state, but has a much 
longer lifetime (typically > 500 ns). This increases the probability of energy transfer to 
other molecules. The triplet state lifetime influences the probability for the interaction with 
surrounding molecules. The energy of the excited photosensitizer molecule can then be 
transferred to molecular oxygen or other molecules by the two reaction mechanisms 
described below. The photosensitizer is not destroyed in this process, but returns to its 
ground state without chemical alteration and is able to repeat the process of energy 
transfer to oxygen many times.  
 
Type I reaction involves electron/hydrogen transfer directly from the excited 
photosensitizer to another molecule via electron/hydrogen abstraction. In this reaction free 
radicals are formed. These radicals then react rapidly, usually with oxygen, resulting in the 
production of highly reactive oxygen species. These react in turn with tissue and causes 
irreversible damages. 
 
Type II reaction produces the electronically excited and highly reactive state of oxygen 
known as singlet oxygen. Direct interaction of the excited triplet state photosensitizer with 
molecular oxygen (which unusually has a triplet ground state) results in the 
photosensitizer returning to its singlet ground state and the formation of singlet oxygen.  
 
In PDT, it is difficult to distinguish between the two reactions mechanisms. There is 
probably a contribution of both type I and II processes, indicating the mechanism of 
damage is dependent on oxygen tension and photosensitizer concentration. The oxygen 
radicals produced are very reactive, and attack cellular targets. The diffusion distance of 
singlet oxygen in biological tissue has been estimated in the order of 0.01 µm, 
corresponding to a lifetime of about 0.01-0.04 µs50,182. The PDT mechanism has been 
summarized in Figure 7.1.  
 
 
Figure 7.1 Three essential constituents in photodynamic therapy. 
 
Photosensitizing agent 
Singlet oxygen Light 
Oxygen 
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What is of interest for this thesis is ALA-induced PpIX as a photosensitizer. Accumulation 
of PpIX in tissues can be achieved by administration of its precursor 5-aminolevulinic acid 
(ALA), either systemically or topically183,184. ALA is a naturally occurring amino acid, 
which in normal biosynthesis of haem, is produced in mitochondria. After a few enzyme 
effective conversions, PpIX is formed, which finally is converted into haem by a special 
enzyme, called ferrochelatase (FeC), that inserts an iron atom into PpIX184. Exogenously 
administered ALA enters the haem biosynthesis pathway, and increases amounts of 
intermediate porphyrins, as FeC is not able to immediately convert all of the produced 
PpIX into haem. In this way, PpIX accumulates temporarily in the tissue.  
 
It has been shown that just like haematopophyrin derivative185,186, the ALA-induced PpIX 
is selectively accumulated in tumor tissue187. In case of systemically application of ALA, 
the selectivity is mostly explained by altered enzymatic activity in the tumor cells188,189. 
For topical application of ALA in the treatment of dermatological malignancies, the outer 
barrier of skin, called the stratum corneum (SC), seems to be the factor of major 
importance for the selectivity. This protective layer has a large impact on the penetration 
of ALA through the skin188. ALA rapidly penetrates through the damaged SC covering a 
tumor, while the surrounding normal skin tissue with intact SC is less permeable190,191. 
 
 
7.4 Light and PDT 
 
Both coherent and incoherent light sources can be used in PDT192. Lasers as coherent, 
monochromatic light sources are widely used because of their advantages over other types 
of light sources. Using laser light, there is the possibility of obtaining a specific 
wavelength that can match the absorption band of the photosensitizer used. In this way, 
exposure to inactive light outside the absorption band of the photosensitizer can be 
avoided. This light only contributes to generation of heat in the tissue. Also, laser light can 
more efficiently be coupled into optical fibers, and guided to tissue, e.g. for interstitial 
illumination24. Filtered lamps, as incoherent light sources, are also employed in PDT, 
especially in ALA-PDT of skin lesions179,191,193. Small size, simple operation, and low 
costs, are the major advantages of these types of light sources. They are, however, all 
limited to superficial illumination, as the light generated is not efficiently coupled into 
optical fibers. To optimize the treatment response in PDT, it is very important to know the 
absorption peak of the used photosensitizing agent. Therefore, whatever the choice of light 
source is, two aims need to be achieved; firstly, the wavelength must match the absorption 
of the sensitizer to get the desired photochemical reaction, and secondly, the light must be 
able to penetrate the tissue to the full depth of the tumor extent.  
 
One of the most important limiting factors in PDT, is the light penetration depth. For red 
light of about 630 nm wavelength, which often is used in PDT, the penetration depth is 2-5 
mm, depending on the optical properties of the tissue. Shorter wavelengths have much 
shorter penetration in tissue. Moan et al. showed, however, that light at 410 nm could be 
used for inactivating cells to a depth of 2 mm in human skin and muscle tissues194. The 
clinical efficacy of PDT from the light delivery point of view, depends on a few 
parameters such as the fluence rate, total light dose, and the illumination geometry. In 
general the total light dose used for surface illumination is 60–250 J/cm2 with an intensity 
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of 50–150 mW/cm2 when a laser is used; whereas the dose is 30–540 J/cm2 with dose 
rates ranging from 50 to 300 mW/cm2 when a lamp is used192. In each case, one must 
consider that applying light with high fluence rate increases the risk of oxygen depletion, 
as oxygen under these conditions is consumed very fast. Such depletion will inhibit the 
photochemical reaction. In addition, it should also be mentioned, that, due to the high 
scattering in tissue, the fluence rate in the outermost cell layers, is usually higher than the 
applied light intensity.  
 
One way for increasing the response to PDT, is to employ light fractionation195. This may 
improve the oxygenation of the illuminated tissue196,197, and will lead to the generation of 
more singlet oxygen and enhance the response to the therapy198. Another option is the use 
of long-term fractionation where two light fractions are separated by an interval of 1 hour 
or longer199. After the first light fraction, PpIX may be partially or completely 
photobleached. New PpIX can then be metabolized during the period until the next 
irradiation, increasing the effectiveness of the treatment195. 
 
 
7.5 Interstitial photodynamic therapy 
 
A major drawback of PDT is that it is limited to thin (<3mm) superficial lesions or lesions 
accessible through body cavities only. The tumor-eradication depth achievable in surface 
irradiation is limited to 3–5 mm because of tissue absorption200. An alternative for PDT to 
treat thick lesions or embedded tumors is to utilize optical fibers inserted into the tumor201. 
This method is called interstitial photodynamic therapy (IPDT)202,203.   
 
An instrument for IPDT has been developed by the company SpectraCure AB (Ideon 
Research Park, Lund, Sweden). This instrument was used during the studies presented in 
Paper III. A general schematic drawing of the instrument is shown in Figure 7.2. The 
instrument uses a maximum of six bare end optical fibres that are used to deliver the 
therapeutic light into the tumor mass. The same fibers can also be used in order to perform 
diagnostic measurements during the treatment session201. The therapeutic light unit 
consists of six diode lasers emitting at 635 nm with an individual maximum output power 
of 200 mW. While in treatment mode, light from the therapeutic light unit is guided into 
the light distribution module and further coupled into the six 400 μm diameter fibers, 
which deliver the light to the target tissue.  
 
In the measurement mode, light from the diagnostic light unit is coupled into one of the 
“patient fibers” via the light distribution module. After interacting with the sample the 
fluorescence light is collected by the other fibers and coupled into an imaging 
spectrometer covering the spectral range between 620 and 810 nm. A cut-off filter (Schott 
RG665) is used to attenuate the intense laser light at 635 nm from the laser light source. 
Wavelength calibration of the spectrometer is carried out using an HgAr lamp to 
determine the relation between wavelength and pixel number in the horizontal direction of 
the CCD chip201. 
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Figure 7.2. A schematic description of the interstitial photodynamic therapy system.  
Modified from Ref201 . 
 
 
7.6 Important parameters in PDT 
 
The path of the drug administration, affects the distribution of the photosensitizer. Topical 
application results in a superficial and local distribution, and is thus suitable for local 
treatment, with minimal risk of phototoxic reactions in other organs204. Systemic drug 
administration, results in a wide drug distribution that is not limited by the diffusion of the 
drug, but allows treatment of thicker tumors. The price to pay is a more general 
photosensitization in other organs. Whatever choice of drug administration, there many be 
different factors influencing the distribution of the drug, such as skin permeability and 
drug diffusivity (for topically applications), pH, temperature, photobleaching, enzyme 
activity, anaesthesia effects, etc. This affects the efficacy of the treatment and must be 
taken under consideration in the treatment planning. Among all these factors, the 
diffusivity and temperature effects are the main subjects of investigation in the work 
described in this thesis, but other parameters of importance for PDT will also briefly be 
discussed.   
 
 
7.6.1 Photobleaching 
 
Studies of in vivo and in vitro laser-induced fluorescence show that the administrated drug 
is degraded during the PDT procedures, resulting in a decreased drug-related fluorescence. 
This phenomenon is called photobleaching24,205,206. Photobleaching plays an important role 
in PDT dosimetry. It has been shown that it is possible to take advantage of the bleaching 
to improve the tumor selectivity of PDT207. As the concentration of sensitizer often is 
larger in tumors than in most surrounding tissues, it is possible to choose sensitizer 
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concentrations that are so low that normal tissues remain almost undamaged, due to 
bleaching, while the therapeutic threshold is exceeded in the tumor174,207.  
 
The understanding is that photobleaching is caused by oxidation of the photosensitizer due 
to generation of singlet oxygen during the PDT procedures. It has been shown that blue 
light causes more rapid photobleaching than red light, and that, under illumination with 
red or blue light, delivery of a fixed light dose at a lower intensity results in more 
photobleaching208. The degree of bleaching depends on the energy absorbed by the 
photosensitizer209.  
 
 
7.6.2 Enzyme dependency of PDT 
 
As already discussed, PpIX is one of the intermediate products in the haem-cycle 
synthesis, and that ALA is the first step, which initializes the cycle. All the chemical 
reactions in the cycle, from ALA to PpIX and haem, are enzyme dependent. This shows 
the importance of enzymatic reaction in ALA-PDT. Moreover, investigations on 
enzymatic reactions during PDT show that photodynamic inhibition of enzymatic cell 
detachment may be related to PDT-induced inhibition of tumor metastasis. Therefore, 
PDT may not only destroy tumor tissues but also reduce the risk for cancer metastases. 
This is one of the advantages of this cancer treatment method. One of the reasons for this 
phenomenon may be inhibition of detachment of cancerous cells from the primary 
tumor210. 
 
 
7.6.3 Oxygenation 
 
The effectiveness of PDT is determined by many factors - one of the most important factor 
being the availability of molecular oxygen in the target tissue during light irradiations211. It 
can be summarized by stating that without oxygen, PDT will have literally no tumor cure 
effect212,213. Tissue oxygenation will change during the course of PDT because of oxygen 
consumption in the photochemical process, which is a photooxidation process. At high 
fluence rates of light, the supply rate of oxygen cannot compete with the consumption 
rate214,215. Thus, the oxygen tension will decrease and the haemoglobin/oxyhaemoglobin 
ratio will increase. At low fluence rates of light, long exposure times are needed, and 
vessel damage may occur during the light exposure216,217. This will also lead to oxygen 
depletion. Changing the oxygen tension in tissue will also lead to a change in the 
deoxyhaemoglobin/oxyhaemoglobin ratio and thus the absorption spectrum of tissue218, 
altering the light penetration. 
 
 
7.6.4 pH in PDT efficacy 
 
One of the important factors that influence PpIX formation from ALA is the pH. Maximal 
PpIX formation is achieved by adjusting the pharmaceutical formulation of ALA or its 
derivatives to physiological conditions with pH = 7.5 ± 0.5219. The activity of enzymes 
involved in the biosynthetic pathway of haem, have optimal activity in pH between 7 and 
7.5. It has been found that PpIX production is more drastically reduced under acidic than 
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under alkaline condition219,220. While the decrease of PpIX formation at higher pH values 
can be attributed to a reduction of cell viability, the decrease under acidic conditions can 
be attributed to either a pH-dependent drug uptake or a reduced enzymatic activity in the 
biosynthesis of haem219. It has been shown that tumor selectivity of some photosensitizers 
such as hematoporphyrin IX (HpIX), which will be more lipophilic at decreasing pH 
values, is related to the low pH of the extra-cellular fluid221. 
 
 
7.6.5 Temperature effects in PDT 
 
Many laser applications in medicine produce heat-inducing alterations of the optical 
properties of the tissue222, which is the result of changes in chemical and structural 
properties. For example, a reduction in the anisotropy factor caused by heat, will result 
variation in the redistribution of light within the tissue, and in particular, the penetration of 
the light within the tissue will be reduced222. Absorbed optical energy generates heat in the 
tissue. The heating may act synergistically with PDT223. It has been shown, that 
hyperthermic cell killing (temperature ≥ 44°C) becomes important for surface irradiance. 
The role of temperature in IPDT is very important, as well. Presence of a high light 
fluence rate nearby the source fiber might increase the tissue temperature, and hence affect 
the treatment results224. The available laser power in clinical PDT using surface irradiation 
generally prevents inadvertent hyperthermia effects, while the power densities are much 
higher close to the delivering fibers in IPDT223.  
 
The synergistic cell killing is one reason why the tissue temperature can play an important 
role in PDT. The tissue temperature will also influence other PDT parameters of 
importance for the treatment outcome: it may affect on the light distribution in tissue as 
the optical properties are temperature dependent, and it is also considered as an important 
factor for drug distribution. It is shown the penetration of ALA into the skin is almost 
temperature independent, while the following production of PpIX has been found to be a 
strongly temperature-dependent process. Practically no PpIX is formed in the skin as long 
as skin temperature is kept low (12-18°C)225. Investigations show that the conversion of 
ALA and its esters into PpIX is temperature-dependent process226. PpIX fluorescence 
detected during the first hour of topical application of drug is 2-3 times higher at normal 
skin temperature (36-37°C) than at lowered skin temperature (28-32°C)226. Another 
investigation shows that, during topical application of ALA on human skin, the PpIX 
fluorescence increases about 50% by increasing the temperature from 31°C to 36°C227. It 
has also been shown that a short period of anaesthesia decreased the production of PpIX 
following topical application of ALA, as the anaesthesia lowers the metabolic activity and 
decreases the skin temperature226. It is often observed that tumors have higher temperature 
compared with surrounding normal tissues, and this can be one of the reasons that PpIX 
accumulation in tumors is higher that the surrounding area188.  
 
Interestingly, an increase in the absorption coefficient of tissue in the range of 60-100%, 
after PDT has been observed228. This might be due to the tissue microcirculation, local 
hyperthermia, bleeding at the fiber tips, and tissue deoxygenation (because of oxygen 
consumption during PDT)201,229,230; though, the main reasons seem to be the tissue 
deoxygenation and changes in blood volume during the photosensitizing action231. 
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In Paper III, the temperature at the source fibers during IPDT has been monitored both 
interstitially and superficially. A technique was employed, where an Alexandrite crystal, 
with temperature dependent fluorescence properties was placed at the fiber tip. 
Measurements on the skin showed a temperature increased in the range of 2-4°C, which 
after a short time (3-4 min), became constant. Moreover, measurements on tissue 
phantoms, yielded similar results as those from superficial skin measurements, although a 
difference in the level of the temperature increase was observed in the measurements. The 
absence of blood flow in tissue phantom measurements as compared to the skin can 
explain this difference.  
 
 
7.7 Drug distribution in PDT 
 
The pharmacokinetics of fluorescent drugs depends on the type and formulation of the 
drug, the type of tissue, the method and period of the application and the drug dose. These 
parameters all determine the optimal time for treatment or diagnostics in PDT232. In 
topically drug administration, the rate of diffusion of the drug is determined by the 
concentration gradients and by a mainly tissue characterizing parameter, usually referred 
to as the diffusion constant or diffusivity. The diffusivity is dependent on the properties of 
the tissue as well as on the chemical properties of the drug molecule233. 
 
 
7.7.1 Skin and its permeability 
 
The efficacy of topically applied drugs is often limited by their poor penetration into the 
skin234. The skin is the largest organ of the human body (15-20% of the total body weight), 
with an area in an adult male of about 2 m2. The main layers of the skin are the epidermis, 
the dermis and the subcutis/hypodermis116. The dermis contains capillaries, sebaceous and 
sweat glands, hair follicles and nerves; the epidermis, on the other hand, is the outermost 
protective layer towards the environment and represents the different stages of cell 
differentiation. The hypodermis is composed mainly of loose connective tissue and fat 
cells, serving as an insulation layer and a connecting link to the underlying tissue. Moving 
outwards from the basal layer of the epidermis, the cells change in an ordered fashion 
from metabolically active and dividing cells to dense, functionally dead, keratinized cells. 
These latter cells are surrounded by lipid layers and constitute the outer 10–20 μm of the 
epidermis, called the stratum corneum (SC). The skin structure is shown in Figure 7.3. The 
barrier function of mammalian skin is principally attributed to the SC235. The barrier 
properties are based on the specific content and composition of the SC lipids, and in 
particular, the exceptional structural arrangement of the intercellular lipid matrix and the 
lipid envelope surrounding the cells236, which make a ‘brick-and-mortar’ model, as is 
shown in Figure 7.4.  
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As stated above, drug permeability through the skin is usually limited by the permeability 
of the SC and also to some extent by the diffusivity of the other skin layers. Two pathways 
through the intact barrier can be identified: the intercellular lipid and the transcellular 
routs; that is, in both cases the permeant must penetrate through some of the intercellular 
lipid matrix237. Figure 7.4 schematically illustrates these pathways. 
 
                                                                     
 
 
The barrier formed by SC is characterized by its permeability. The effect of the barrier on 
the drug distribution is maximum immediately after application of the drug to the skin, and 
the relative importance of the barrier decreases with time238. Moreover, the permeability 
can be increased by disordering the SC lipids. Fatty acids are a class of compounds 
frequently used to increase uptake rates of topically applied drugs, and they are generally 
believed to increase the permeability across the SC. In topical application of drugs, the 
drug must not only enter the SC efficiently, but it must also be able to diffuse through the 
remaining skin layers. Thus, a successful drug has a balanced lipophilicity and possesses 
some aqueous solubility239. A solution to the problem of getting drugs to penetrate the skin 
might be the use of chemicals that alter the structure and permeation properties of SC in 
such a way that penetration of drugs through this major barrier is facilated240. Another 
Transcellular rout Intercellular rout 
Figure 7.4 Permeation routes 
through the stratum corneum,  
(i) transcellular rout, (ii) 
intercellular rout. 
Figure 7.3 Skin structure, 
adapted from Ref147. 
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approach to facilitate the penetration of drugs is removing the SC by tape stripping the 
skin before drug application241. The barrier effect of SC is usually strongly reduced in 
regions of superficial tumors238. 
 
 
7.7.2 ALA and its esters 
 
One limiting factor in PDT with topical drug application is the transport of the drug into 
the tumor. This can limit the treatment depth more than the penetration of the treatment 
light. The time required for ALA to diffuse to a depth of 2.5 – 3.0 mm may range from 3 
to 15 h233. The molecular weight of ALA is 168, and it is a hydrophilic molecule. The 
hydrophilic nature of ALA restricts drug penetration through the keratinous layer of 
normal skin (SC); however, this problem may be alleviated by the use of more lipophilic 
ALA esters. In other words, since the skin penetration of molecules of similar size as ALA 
increases with increasing lipophilicity, ALA esters, which are more lipophilic than ALA 
itself, are introduced for PDT of skin tumors. However, SC may bind the esters 
temporarily, and thereby slow down their penetration into the living cells where PpIX is 
formed242. The pharmacokinetics of ALA and ALA-esters may therefore be relatively 
different.  
 
It has also been reported that ALA esters need to be hydrolyzed to ALA before they can 
enter the haem biosynthesis cycle226. ALA esters seem to be more selectively producing 
PpIX in some tumor types than ALA243. As more PpIX is formed at higher temperatures, 
this could be one of the reasons for the tumor selectivity of ALA esters244. The PpIX 
formed from ALA-esters and ALA has been found to be equally efficient in 
photoinactivation of cells245.  
 
It is important to understand all the different components of the treatment in detail in order 
to be able to optimize the treatment result. In PDT the concentration and distribution of the 
drug is an important dosimetric parameter. Simple mathematical description of PDT 
components constitutes a dosimetry model. The permeability through SC and the 
diffusivity in the remaining skin layers of ALA are very important factors, because they 
determine the distribution and also the concentration of the drug. A dosimetry model, not 
only provides a mathematical model to describe light and drug distribution, but also opens 
for possibilities to optimize the treatment. Therefore, the diffusivity or diffusion 
coefficient is one of many important parameters for PDT. The diffusivity of ALA 
determines the drug concentration and distribution, and will strongly influence the efficacy 
of topical ALA-PDT. So far, no records of diffusivity measurements of ALA and/or its 
esters have been reported.  
 
Considering the fact that at optimal conditions, ALA esters induce higher PpIX 
concentration at deeper tissue layers246; Methyl-ALA (M-ALA) was used for 
concentration measurements in Paper IV. M-ALA has a wide range of application in 
dermatology for treatment of cancers by PDT. For this purpose, M-ALA cream 
(METVIX® 20 %, PhotoCure, Oslo), was used for measuring the drug concentration as a 
function of time after topical application at a specific depth (500µm) of normal skin in 
vivo, by using a Microdialysis device (see Chapter 5) with 100 KD cut-off membrane. One 
of the aims of this study was to understand the diffusivity of the M-ALA, which would be 
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necessary for developing an improved dosimetry model for PDT. Samples were collected 
during a few hours with a 1 h interval, starting with the application time. The drug was 
traced in the samples with both High Performance Liquid Chromatography-Flourimetric 
detection, and Liquid Chromatography Mass Spectroscopy.  
 
HPLC with a fluorimetric detector was not sufficiently sensitive to measure all different 
concentrations of M-ALA in the samples. The detection limit for M-ALA was in the 
region of 100 ng/ml and 300 ng/ml in buffer and sample, respectively. In MALDI-TOF 
MS, the detection limit for M-ALA was lowered to approximately 5 ng/ml.  
 
These measurements show the very low drug concentration in the samples. The 
concentration of M-ALA was below the detection limit in the samples. Again, the barrier 
function of the SC was proved. In another attempt, the samples were collected in a purer 
form by utilizing 20 KD membrane in the microdialysis probe. In spite of a very good 
optimization, still the concentrations of the drug in the collected samples were below the 
sensitivity of the used detection techniques. It is planned to repeat these measurements 
following administration of the drug on tape-stripped skin, to increase the concentration of 
the drug in the depth beneath the SC, and measure the diffusivity in this condition. 
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Summary of papers 
 
 
 
In Paper I, a fast and accurate method for real-time determination of the optical properties 
of thin turbid samples by using simple continuous-wave non-coherent light sources is 
presented. The applied multivariate calibration and prediction techniques are based on 
multiple polynomial regressions in combination with a Newton–Raphson algorithm. The 
numerical test results are based on Monte Carlo simulations. For this purpose, a novel 
compact instrument, called the Combined Angular and Spatially Resolved Head sensor 
(CASH sensor), has been designed and developed, which together with some preliminary 
results is introduced in the paper. 
 
In Paper II, measurements of the optical properties of porcine brain tissue are presented, 
using the CASH sensor. These results are compared with the obtained results from an 
integrating sphere system, and the published data on human brain tissue, as reference.  
 
Paper III, considers that the tissue temperature may increase during the treatment by 
PDT/IPDT due to absorption of the treatment light. A system to measure the local tissue 
temperature at the source fibers during IPDT on tissue phantoms and on healthy volunteers 
is presented. 
 
Paper IV, deals with a method to measure the distribution and rate with which a 
photosensitizer penetrates skin. This is very important for PDT of skin lesions following 
topical application of the drug. The diffusion coefficient is the factor used to determine the 
distribution and concentration of the drug in tissue. Results from measurements on 
microdialysis samples collected in healthy volunteers following topical application of 5-
aminolaevulinic acid methyl ester are presented. These measurements are the first step 
towards our next goal, being the construction of a dosimetry model for the treatment in 
PDT.  
 
In Paper V, the optical properties of pig brain tissue have been measured, employing 
different calibration method, comparing with what is presented in paper II. 
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